Age, modifiable risk factors, and mortality. : A 42 years prospective follow-up study in a general population. by Gulsvik, Anne Kristine
 
 
 
Age, modifiable risk factors, and mortality.  
 
 
A 42 years prospective follow-up study in a general population. 
 
 
 
 
 
 
 
 
 
 
Anne Kristine Gulsvik, MD 
 
 
 
 
Dissertation for the degree of philosophiae doctor (PhD) 
at the University of Oslo 
 
 
2011 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
© Anne Kristine Gulsvik, 2012 
 
 
Series of dissertations submitted to the  
Faculty of Medicine, University of Oslo 
No. 1295 
 
ISBN 978-82-8264-337-5 
 
 
All rights reserved. No part of this publication may be  
reproduced or transmitted, in any form or by any means, without permission.   
 
 
 
 
 
 
 
 
Cover: Inger Sandved Anfinsen. 
Printed in Norway: AIT Oslo AS.  
 
Produced in co-operation with Unipub.  
The thesis is produced by Unipub merely in connection with the  
thesis defence. Kindly direct all inquiries regarding the thesis to the copyright  
holder or the unit which grants the doctorate.   
 
3 
 
Acknowledgements 
I would like to thank: 
Professor Torgeir Bruun-Wyller, Department of Geriatric Medicine (UiO), my principal 
supervisor, for your trust and patience, your always valuable advices, constructive criticism, 
linguistic cleverness and for your 24-7 availability which is unequalled.  
Professor Dag Steinar Thelle, Department of Biostatistics (UiO), my second supervisor, for 
your valuable comments and guidance. Thank you for your superior methodological focus. 
Your vast research experience and impressive professional calm have reassured me many 
times. 
Associated Professor Morten Mowé, Department of General Internal Medicine, Aker (UiO), 
my third supervisor, for your ability to express constant enthusiasm and confidence in me. I 
always feel more capable, cleverer, and more inspired after meeting with you. 
Professor Eva Skovlund Department of Pharmaceutical Biosciences (UiO) and Professor 
Sven Ove Samuelsen Division of statistics and insurance mathematics (UiO) for your 
comments, your statistical support and assurance, and for introducing the words model 
fitting and bootstrapping to my vocabulary. 
Professor Einar Svendsen and Professor Bjørn O. Mæhle, Department of Pathology, The 
Gade Institute, Haukeland University Hospital (UiB), for access to the autopsy data and help 
to understand the autopsy procedures and coding system. 
Coauthor and colleague Marius Myrstad, Department of Geriatric Medicine, 
Diakonhjemmet Hospital, for your helpful comments on the benefits of physical activity and 
for the Birkebeiner 2011 adventure.  
Dr. med. Sjur Humerfelt at the Department of Thoracic Medicine, Aker, for collecting data 
in the follow-up survey in 1988-90 and for support on my forth paper. Your contributions 
made that paper unique. 
All my colleagues at Loftet, Ullevål: Anne L, Unni, Leiv-Otto, Nina O, Maria B, Janne, 
Marit, Knut, Vibeke, Anne-Lise, Hege I-H, Siri, Anne-Brita, and Marte M, who have 
contributed to my mental health at work. Special thanks to Anne Garmark who kindly takes 
care of everybody. 
Ragnhild and Marte H with whom I’ve shared the numerous horrors and delights of 
research, parenthood, marzipan and the combination of all. 
4 
 
My chief during the final months of finishing this thesis, professor dr. med Dag Jacobsen at 
the Department of Acute Medicine, OUS, Ullevål, who made it possible for me to finish 
while working full-time as a clinician. 
All those involved in the Bergen Clinical Blood Pressure Survey (BCBPS), who made it 
possible for me, more than 40 years later, to present this thesis. The BCBPS was conducted 
by several research workers, especially Olav Sulheim (principal field physician) and his 
staff of field workers who included Randi Fagerås, Kirsten Opheim, Alvhild Styve, Ingelev 
Monsen, Leikny Vannes, Else Winge, and Erna Ramm, Ernst Risan, Eilert Eilertsen and 
Sigurd B. Humerfelt.  
Both my parents Haldis and Amund Gulsvik. Without your conviction in my abilities and 
support during the different challenges and phases of my work this thesis would never have 
taken place. My father’s good ideas, persevering eagerness and support encouraged my 
interest in the field of epidemiological research.  
Finally my thanks go to Espen for his approval and support to work with this thesis and his 
patience with my perpetual attraction to new challenges. Everlasting love goes to our 
children Haldis and Aksel who persistently reminds me of the important issues of life and 
who enables me to unhook and to put my work into perspective.  
 
 The work presented in this thesis has been performed at the Department of Geriatric 
Medicine at the University of Oslo. The baseline data of this study was collected in the 
Bergen Clinical Blood Pressure Survey (BCBPS) conducted in 1965-71 and the follow-up 
data was collected in the Occupational Lung Function Survey (Støvlungeundersøkelsen) in 
1988-90. The BCBPS was funded by the Norwegian Council for Cardiovascular Disease 
and the World Health Organization. The Occupational Lung Function Survey was supported 
by the Research Council of Norway, Confederation of Norwegian Business and Industry, 
Norwegian Cancer Society, Norwegian Asthma and Allergy Association, Glaxo Norway 
AS, Norwegian Oil AS, Tordis and Fritz C. Rieber’s Legacy, Stefi and Lars Fylkesaker’s 
Foundation, Gerd and Fredrik Johan Grahl’s Legacy. Alexander Malthe’s Legacy, Laurine 
Maarschalk’s Fund, Roll’s Legacy, Alfred and Therese Schnelle’s Legacy, Astrid and 
Birger Torsted’s Legacy and the Department of Thoracic Medicine, Haukeland Hospital. 
My work on this thesis has been financed by the Department of Geriatric Medicine, Ullevål, 
University of Oslo. 
5 
 
Contents 
Acknowledgements .................................................................................................................... 3
Contents...................................................................................................................................... 5
Norsk sammendrag..................................................................................................................... 7
Abbreviations ............................................................................................................................. 8
List of Papers.............................................................................................................................. 9
1 Introduction ......................................................................................................................... 11
1.1 Successful ageing............................................................................................................ 11
1.2 Modifiable risk factors of mortality ................................................................................ 11
1.2.1 Body mass .................................................................................................................. 12
1.2.2 Physical activity ......................................................................................................... 13
1.2.3 Lung function ............................................................................................................. 14
1.3 Mortality and cause of death........................................................................................... 15
2 Aim of the study .................................................................................................................. 17
3 Material................................................................................................................................ 18
3.1 Bergen Clinical Blood Pressure Survey.......................................................................... 18
3.2 Follow-up 1988-90.......................................................................................................... 19
3.3 Death surveillance........................................................................................................... 19
4 Methods ............................................................................................................................... 22
4.1 Body Mass Index ............................................................................................................ 22
4.2 Physical activity assessment ........................................................................................... 22
4.3 Lung function measurements .......................................................................................... 23
4.4 Variables for adjustment ................................................................................................. 24
4.5 Mortality Statistics .......................................................................................................... 25
4.6 Post mortem examination ............................................................................................... 26
4.7 Statistics .......................................................................................................................... 26
4.7.1 Basic statistical terms and Kappa statistics ................................................................ 26
4.7.2 Descriptive statistical tests ......................................................................................... 27
4.7.3 Logistic regression ..................................................................................................... 28
4.7.4 Survival analyses and proportional hazard assumption ............................................. 29
4.7.5 Bias reduction............................................................................................................. 33
4.8 Ethical considerations ..................................................................................................... 33
5 Results ................................................................................................................................. 34
5.1 Synopsis of papers .......................................................................................................... 35
5.1.1 Paper 1: Endpoint ascertainment................................................................................ 35
5.1.2 Paper 2: Body mass and all-cause mortality in different age-ranges ......................... 35
5.1.3 Paper 3: Physical activity and mortality in different age-ranges. .............................. 37
5.1.4 Paper 4: Lung function and mortality from stroke..................................................... 38
6 Discussion............................................................................................................................ 41
6.1 Methodological considerations ....................................................................................... 41
6.1.1 Study design ............................................................................................................... 41
6.1.2 Bias ............................................................................................................................ 41
6.1.3 Confounding............................................................................................................... 42
6 
 
6.1.4 Reliability................................................................................................................... 43
6.1.5 Validity....................................................................................................................... 43
6.1.6 Causality..................................................................................................................... 44
6.1.7 Long term-follow up and time-dependent covariates ................................................ 44
6.1.8 Stroke incidence vs. stroke mortality ......................................................................... 45
6.1.9 Summary .................................................................................................................... 45
6.2 Discussion of the main results ........................................................................................ 45
6.2.1 Validity of fatal stroke and coronary deaths in mortality statistics............................ 45
6.2.2 BMI and mortality...................................................................................................... 46
6.2.3 Physical activity and mortality................................................................................... 48
6.2.4 Lung function and mortality ...................................................................................... 49
7 Conclusion........................................................................................................................... 53
8 Suggestions for further research.......................................................................................... 54
9 References ........................................................................................................................... 55
10Papers ..................................................................................................................................68
11Literature tables ................................................................................................................11-1
12Appendix: The original questionnaire ..............................................................................12-1
 
 
7 
 
Norsk sammendrag 
Risikoforebygging er en viktig del av alt helsearbeid, men det meste av evidens med hensyn 
på forebyggende helsearbeid er fremkommet ved studier utført på middelaldrende 
befolkningsgrupper med ulik ekstern validitet, med variabel oppfølgingstid, og med 
overvekt av menn. Modifiserbare risikofaktorer har potensielt ulik innvirkning i ulike 
aldersgrupper, i ulike faser av en lengre oppfølgingstid og med hensyn på forskjellige 
endepunkter (dødelighet: total og årsaksspesifikk).  
Målsetning: å studere forskjeller og likheter i effekten av livsstilsrelaterte risikofaktorer 
(særlig kroppsmasseindeks, fysisk aktivitet og lungefunksjon) på total dødelighet og 
årsaksspesifikk dødelighet som følge av hjerneslag og koronar hjertesykdom i ulike 
aldersgrupper av menn og kvinner i en generell norsk befolkning med 42 års oppfølgingstid. 
Materiale og metode: 6811 tilfeldig utvalgte menn og kvinner i alderen 20-79 og bosatt i 
Bergen i 1964 ble invitert til en utvidet helseundersøkelse etter Blodtrykksundersøkelsene. 
5653 personer møtte frem til undersøkelsen der 208 kliniske og selvrapporterte variabler ble 
registrert. Datamaterialet ble koblet mot Levekårsundersøkelsene i 1970-80-90 og 2000, 
Dødsårsaksregisteret (2005) og Folkeregisteret (2007). Cox-regresjon ble brukt for å studere 
sammenhengen mellom utvalgte variabler og dødelighet. 
Resultater: Kroppsmasseindeks er assosiert til overdødelighet i yngre aldersgrupper, men er 
tilsynelatende inverst assosiert til dødelighet i eldre aldersgrupper, selv etter justering for 
multiple variabler og i subgruppeanalyser av de friskeste i utvalget. Fysisk aktivitet er minst 
like sterkt assosiert til overlevelse blant de eldre som i de yngre aldersgruppene, i 
motsetning til de fleste andre kjente risikofaktorer som har avtakende styrke i sin 
assosiasjon til død med økende alder. Lungefunksjon er inverst assosiert til risiko for 
dødelig hjerneslag. Validiteten av hjerneslag og koronar hjertesykdom registret som 
tilgrunnliggende dødsårsak i Dødsårsaksregisteret i perioden 1965-2005 er tilfredsstillende 
for bruk i epidemiologisk forskningsarbeid.      
Konklusjon: Livsstil har implikasjoner for overlevelse i alle aldersgrupper. Fysisk aktivitet, 
kroppsmasseindeks og lungefunksjon er viktige livsstilsrelaterte prediktorer for god helse og 
økt overlevelse også blant gamle.  
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1 Introduction 
1.1 Successful ageing 
Resiliency and longevity are the opposites of frailty and mortality. When searching the 
literature for the word “ageing” these two more favorable words is much less used than their 
unfavorable counterparts. Ageing is a process of age-related cumulative declines across 
multiple physiologic systems, eventually leading to frailty with impaired homeostatic 
reserve and a reduced capacity of the organism to resist stress and functional decline. 
Biological age can be assessed using a profile of physical measurements and FEV1 has been 
suggested as an important biomarker of ageing 11;23. Frailty is a clinical syndrome associated 
with ageing and it includes unintentional weight loss and low physical performance and 
activity 56;213.  Interventions to try to delay the ageing processes imply that we can assess the 
individuals at risk. Studies assessing risk factors of functional decline define the outcome as 
a threshold decrease in activities of daily living (ADL), an evolving need for 
institutionalization or as mortality (definitively not functioning at all) 116.  The risk factors, 
causes and cofactors form a complex array and hence frail individuals at risk of functional 
decline benefit from the interdisciplinary management and treatment in geriatric units when 
hospitalized 16;157.   
1.2 Modifiable risk factors of mortality 
Risk factors or predictors of premature mortality may be fixed or modifiable. Prevention 
strategies focus mainly on modifiable factors but fixed predictors such as age and sex may 
be useful in guidance about whom and when to treat. Under the common (but rarely tested) 
assumption that the relative benefits of intervention are the same for different patients 
groups, greater absolute benefits may be expected for patients with higher underlying risk of 
disease. The balance of benefits and side effects may thus depend on the level of fixed risk 
factors. Risk evaluation strategies have so far mostly been based on data obtained from 
middle-aged populations, and aiming to prevent ischemic heart disease. As an example The 
British Regional Heart Study have reported that modifiable lifestyles (smoking, physical 
activity and BMI) in middle aged men play an important role in long-term survival free of 
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ischemic heart disease, stroke and diabetes200. Modifiable risk factors also play an important 
role in the life expectancy in the elderly19. The relative importance of the different risk 
factors may, however, vary between age strata, and most traditional risk factors have 
declining effect with increasing age19;129;186. In a public health aspect, with growing numbers 
of elderly and very old inhabitants, primary prevention strategies tailored for the elderly are 
increasingly important. 
It has been suggested that 90 % of all health issues are due to general living conditions and 
individual life-style2. Risk factors associated with an unhealthy life-style are potentially 
modifiable without pharmacological intervention and a healthy life-style has to my 
knowledge no unwanted side-effects or interactions in any age-range or subgroups of the 
population. The long-term effects of life-style interventions are nevertheless difficult if not 
impossible to study in randomized controlled trials and the evidence is largely based on 
prospective cohort studies. Routinely interventions in people at risk are considered less 
applicable and are still uncommon compared to pharmaceutical therapies – especially in the 
elderly. 
1.2.1 Body mass 
Worldwide, obesity and overweight are steadily increasing in all age segments. The World 
Health Organization (WHO) categorizes body mass index (BMI; the body weight in 
kilograms divided by body height in meters squared) in four main categories: underweight 
(BMI<18.5 kg/m2), normal weight (BMI 18.5-25 kg/m2), overweight (BMI 25-30 kg/m2) 
and obesity (BMI 30+ kg/m2) 209. The current knowledge of the relationship between BMI 
and mortality began with the life insurance studies in USA developing from the 1950es 
87;205. In Norway some of the first international publications on this topic were due to 
Westlund et al in 1972203 and Waaler et al in 1984196. The influence of BMI upon total 
mortality is significant and well documented in the obese segment of the population for all 
age groups 117. Overweight has also been found to be a considerable risk factor in young 
adult men in a recent publication 127. In the younger age groups, a low BMI is usually 
associated with an increased survival after adjusting for smoking habits, but a few studies 
report an increased mortality among thin individuals even in the lower part of the acceptable 
BMI-range (20-25 kg/m2) 146. Below the BMI-range 22.5-25 kg/m2, the overall inverse 
association with BMI is predominantly due to strong inverse associations for smoking-
13 
 
related respiratory disease (including cancer), but the excess mortality in the lower BMI-
range is not fully explained 142.  
In the older age segments, the association between body mass and mortality is even less 
conclusive 37;77;184;214. The relative risk of death associated with a high BMI seems to 
diminish with increasing age 178, and in the older age groups the highest mortality has 
sometimes been reported in the lower BMI segments 36;39. Longitudinal studies are not free 
of bias. Preclinical disease as well as other factors affecting both body mass and mortality 
prior to base-line examination may confound the associations. Unrecognized preclinical 
disease causing underweight is one likely reason for this observation, as the leanest elderly 
have a high fatality rate in the hospital wards 124;125. Another plausible contributory factor is 
a survival bias in cohort studies, implying that obese individuals that do not die young carry 
an extraordinary degree of biological robustness. The possible inverse relationship between 
BMI and mortality in the elderly remains unexplained. An overview of the literature on the 
association between body mass index in different age-ranges and mortality from all causes, 
published in the past 20 years, is presented in Table L-1 (Nordic countries) and Table L-2 
(non-Nordic countries) in the Literature tables section. As we can see from Table L-1 and L-
2 the study populations, follow-up period, categorization of the independent variable, 
adjustments, and conclusions varies between the different studies.  
1.2.2 Physical activity 
 When centenarians and other long-lived individuals are studied, their longevity is often 
attributed to a healthy lifestyle. Three characteristic behaviors are routinely reported; these 
include exercising regularly, maintaining a social network, and maintaining a positive 
mental attitude. Regular physical activity seems to be the only lifestyle behavior identified 
to date, other than perhaps caloric restriction, which can favorably influence a broad range 
of physiological systems and chronic disease risk factors, and an active lifestyle may delay 
onset of dementia 54. Despite large differences in genetic background among those of a 
given age cohort, it seems that physical activity may be a lifestyle factor that discriminates 
between individuals who have and have not experienced successful aging 30. 
Sedentary living 135 has assumed epidemic proportions in the industrialized world and 
physical activity (PA) is one of the most important modifiable factors that determine the risk 
of chronic morbidity and high mortality in the population in general. The beneficial effect of 
PA on longevity and the disease-specific risks such as ischemic heart disease (IHD), stroke 
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and cancer has been studied since the 1950s in the adult and middle-aged segments of the 
population, and to a lesser extent in the old 21;98;123;132. For older adults, evidence indicates 
that being physically active is associated with increased longevity, higher levels of 
functional health, a lower risk of falling, better cognitive functioning, and increased social 
integration 30. Men have been studied more extensively than women, younger age-ranges 
more than older ones, and external validity, follow-up time and response rates vary greatly 
in earlier research work 25;134. We are only aware of one previous population-based study 
which includes all adult age groups of both genders and with a follow-up period of more 
than 20 years 93. A major question regarding this amendable risk factor is to what extent PA 
has an effect on longevity above and beyond the recognized mediators of blood pressure, 
blood lipids and body mass, and whether this effect is valid for both genders and all age 
groups.  
The inverse association between physical activity and all-cause mortality has previously 
been reported to be similar in magnitude to the effect of hypertension, hypercholesterolemia 
and smoking alone 141;174, but the relative importance of the different risk factors may, 
however, vary between the age strata 19;129;186. An overview of the literature on the 
association between physical activity in different age-ranges and mortality from all causes, 
published in the past 20 years, is presented in Table L-3 (Nordic countries) and Table L-4 
(non-Nordic countries) in the Literature tables section. As we can see from Table L-3 and L-
4 the study populations, follow-up period, assessment and categorization of physical 
activity, adjustments, and conclusions varies between the different studies. 
1.2.3 Lung function 
Lower lung function is one of many predictors of frailty and mortality. The associations 
between lower lung function, respiratory symptoms, and stroke are still under discussion 
32;57. The relationship between lower lung function and risk of stroke has previously been 
reported for both stroke incidence and stroke mortality 73;198, and the association is 
independent of other risk factors including smoking 83. Asthma has been related to stroke 
and macrovascular disease. 130;159 Some of the previous studies in this field were not 
population based and included men only 180;198. The largest population based study reported 
a response rate of 78% 82. None of the studies published so far have been able to study the 
robustness of the association after more than 20 years of follow up, and all previous studies 
on this inverse relationship are based on one baseline measure of lung function only 40;170.  
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The robust inverse relationship between lung function and vascular events may be due to a 
common, unrecognized, offending factor (fetal or lifetime exposure) that affect both FEV1 
and the vascular system, or it may be due to a causally linked process 170. If the risk of 
stroke were more strongly related to the rate of declining lung function than with the 
baseline lung function levels, this would suggest that the responsible mechanisms are 
mainly operating in adult life 40. An overview of the literature on the association between 
lung function and cerebral stroke published in the past 20 years is presented in Table L-5 in 
the Literature tables section. As we can see from Table L-5 the study populations, handling 
of the independent variable (FEV), adjustments, validity of the endpoint (stroke), and 
conclusions varies between the different studies. 
1.3 Mortality and cause of death 
The specific cause of death reported in mortality statistics is a common endpoint in 
epidemiological studies and it is generally used as a surrogate marker of morbidity of 
diseases with serious outcome. Different causes of death may have different associations to 
the risk factors of interest. Ischemic heart disease and cerebral stroke are two major causes 
of death in the industrialized parts of world (including Norway) according to mortality 
statistics 210;211. Both the disability and mortality attributable to vascular disease in ageing 
populations highlight the need to identify factors related to etiology and prevention. 
Despite the decreasing autopsy rates, post mortem examination is still regarded as the most 
accurate means of determining the cause of death 143;151. 
Previous studies on the validity of cerebrovascular mortality rates (based on death 
certificates issued by physicians) against autopsy findings have concluded, contradictorily,  
both that validity are unacceptable 176 and that the overall validity is largely reliable 192. 
During the last two decades, as diagnostic technology and procedures have continued to 
improve, only a limited number of studies have been published validating mortality statistics 
on stroke or ischemic heart disease against autopsy findings 104;153;172. These studies were 
based on cohorts selected for post-mortem examinations, and thus not able to address 
external validity. In Norway, the official department known as Statistics Norway compiles 
information on time and cause of death for all deceased inhabitants. The mortality statistics 
regarding stroke and ischemic heart disease in Norway have not been validated against 
autopsy findings since 1977 192. An overview of the limited available literature regarding the 
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correlation between diagnoses on death certificates or mortality statistics and autopsy data is 
presented in Table L-6 in the Literature tables section. 
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2 Aim of the study 
We wanted to study the associations between markers of ageing and mortality and the 
modifying effect of age upon some of these associations. We did this by: 
1. Validating the cause of death recorded as fatal stroke or coronary death in the 
official Norwegian mortality statistics by comparing them to autopsy records. 
2. Exploring the association between BMI and all-cause mortality in different age-
segments, while minimizing possible confounding from known clinical risk factors, 
smoking or bias from sub clinical disease (“reverse causation”).  
3. Exploring the association between physical activity and all-cause mortality, fatal 
stroke and coronary death in different age-segments and compare it to other 
established risk factors. 
4. Studying the independent association between baseline lung function and the risk of 
fatal stroke as well as that of longitudinal changes in lung function upon the risk of 
fatal stroke in a general Norwegian adult population. 
 
3 Material  
The source population of this study was all men and women living within the old city 
borders of Bergen, Norway by Januray 1 1964, and who were born between January 1 1894 
and December 31 1943. The total population in this age-range was 77694 residents. 
3.1 Bergen Clinical Blood Pressure Survey 
The number three was drawn from a hat defining a sample of the target population born on 
the 3rd, 13th or 23rd of each month, and invited to an extensive clinical investigation. 6811 
individuals were invited (3104 men and 3708 women) and they were followed until 2005-7. 
The cohort and the original study protocol have been described in detail previously 68. 
 
 
Figure 1. Flow chart of a random sample of the 6811 subjects from the population of 
Bergen, Norway, invited to the Bergen Clinical Blood Pressure Survey. 
Of these, 67 were excluded because they had died, and six were excluded because they had 
emigrated before the screening had taken place, leaving 6738 eligible subjects. Of these, 
5653 (84%) participated in the study. The start of follow-up for the non-participants was set 
to the median date of the examination of the participants, December 7, 1966. We grouped 
the participants into young adults, aged <45 years at baseline, middle aged, 45-64 years, and 
18 
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older participants aged 65+ years. An extensive array of 208 variables was recorded for each 
participant at baseline, and it included personal and family medical history, age, sex, 
anthropometric measures (height, body weight, skin fold thickness in both the sub scapular 
and triceps region (mm), and triceps circumference (cm)), blood pressure, blood-lipids, 
blood glucose, history of diabetes, heart disease, or pulmonary disease, smoking habits, 
socioeconomic data, nutritional factors, physical findings, urine samples, pulmonary 
function (forced expiratory volume after one second - FEV1), and an electrocardiogram 
(ECG). Procedures for ascertaining the data have been described elsewhere 64-68. 
3.2 Follow-up 1988-90 
The male survivors initially aged 22-54 years and who still lived in the study area (n=1154) 
were invited to a follow-up examination in 1988-90. 1032 (89%) of these men performed 
spirometric maneuvers with valid FEV1-measurements. 953 of these also had valid FEV1 
data from the baseline examination. 
3.3 Death surveillance 
Information regarding cause of death was collected from two different sources namely the 
official Norwegian mortality statistics at Statistics Norway and autopsy records at the Gade 
Institute in Bergen for those of the deceased participants who had a post mortem 
examination.  
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Table 1. Deaths recorded at Norwegian mortality statistics during the cause-specific 
follow-up from 1965-2005 among the 6811 subjects invited to the study.  
 
Men  
N(%) 
Women  
N(%) 
Combined  
N(%) 
Individuals at risk  3104 (45) 3707(55) 6811 (100) 
All deaths (1965-2005) 2149 (69) 2238 (60) 4387 (64) 
Deaths from ischemic heart diseasea 623 (29) 498 (22) 1121 (26) 
Deaths from cerebrovascular 
diseaseb 218 (10) 330 (15) 548 (12) 
a: Eurocode 34; b: Eurocode 36 (both defined in Table 3) 
During the cause-specific follow-up time 4387 persons died and 998 causes of death were 
recorded to be based on autopsy findings according to the official Norwegian mortality 
statistics. The local pathology department at Haukeland sykehus, Bergen (The Gade 
Institute) had records on 1140 post mortem verified causes of death from the same 
population. 742 causes of death were recorded to be autopsy-verified in both mortality 
statistics and the local autopsy records, 398 had autopsy reports at the Gade Institute which 
had failed to be forwarded or recorded at Statistics Norway, and 256 did not have an 
autopsy report at the Gade Institute but where still reported to have an autopsy-based cause 
of death at Statistics Norway (Figure 2). This may be due to death and post-mortem 
examination outside Bergen, tick-off errors in the death certificates or errors in the 
recording procedures at Statistics Norway. 
Study cohort at 
baseline (N 6811) 
Dead by the end of 
follow-up (N 4387)
398 
742 
256 
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Autopsy reports available at the 
Gade Institute (N 1140)  
 
Cause of death recorded at Statistics Norway 
reported to be based on autopsy (N 998) 
Figure 2. Recordings of deaths and post mortem examinations among all the 6811 
invited subjects 
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4  Methods 
4.1 Body Mass Index 
Medical technicians measured height to the nearest centimeter and weight to the nearest half 
kilogram, without outer garments or shoes. All measurements on height and weight were 
made on the same height and weight scale. BMI was calculated as the body weight (kg) 
divided by the square of the body height (m) and was classified  in four ranges: <22.0 
kg/m2, 22.0-24.9 kg/m2, 25.0-27.9 kg/m2, 28.0 kg/m2 due to convenience. The lower and 
upper cut-off points where close to the limits of the respective quintiles of BMI and 
comparable to cut-off points used in previous studies 45;77;100. The medial cut-off point of 25 
kg/m2 corresponds to the WHO´s definition of overweight. The WHO ranges of BMI 
(<18.5, 18.5-24.9, 25-29.9 and 30+) cut-off on extremes on the lower and upper end of the 
scale that apply to few people in Norway. In the interim analysis quintiles of the other 
anthropometric measures mentioned above were tested for their association to death.  
4.2 Physical activity assessment 
Physical activity (PA) was assessed using a standardized interview performed by trained 
nurses and including 6 questions with dichotomous (yes/no) answers, regarding involvement 
in different physical activities during the past 5 years. The respondents who reported “yes” 
to more than one PA-question were categorized according to their highest reported level of 
activity. The respondents answering “no” to all of the 6 questions were assigned to level 7. 
After the preliminary univariate Cox analyses stratified to age the 7 levels of PA were 
merged into 3 and 2 levels as described in paper 3. The 3 levels were largely comparable to 
the 4 level questions originally developed by Saltin & Grimsby during the 1960s 156. Their 
questions regarding PA have previously been found to correlate positively with aerobic 
capacity 110 and their convergent validity has been studied by correlation with 
anthropometric markers and serum lipids 4;188. 
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Table 2. Levels of physical activity (PA) derived from the questionnaire (reported 
as the average during the 5 years preceding the baseline survey).  
The initial seven PA-
questions/levels N 
Collapse into 3  
PA-levels (N) 
Collapse into 2  
PA-levels (N) 
Performing competing sports  76 
Taking regular exercise/gym  644 
High              
(720) 
Walking at least 2 km or bicycling at 
least 5 km at least 3 times a week  1003 
Walking/bicycling to work for more 
than 10 minutes daily  988 
Strolling or gardening  1638 
Moderate           
(3629) 
Any activity       
(4349) 
Performing other kinds of exercise  80 
None of the above  1224 
No/Low            
(1304) 
No/low activity  
(1304) 
 
4.3 Lung function measurements 
The forced expiration maneuvers were measured using a dry-wedge bellow spirometers 
(Vitalograph) both at baseline in 1965-71 (P-model) and at follow-up in 1988-90 (S-model) 
41;86. The highest values of FEV1 and forced vital capacity (FVC) were recorded by trained 
technicians from at least two acceptable attempts. All values used in the analyses were 
corrected to body temperature and pressure saturated conditions (BTPS) 86. Level of FEV1 
and FVC at baseline was expressed in liters (L) whereas the longitudinal change in FEV1 
and FVC between baseline and follow-up was expressed as milliliters decline per year 
(mL/year). The predicted values of FEV1 and FVC were calculated due to the prediction 
equations recently derived and published from the same geographic area 91. As a supplement 
we performed standard adjustments for FEV1 and FVC by expressing these variables as 
percentages of their respective predicted values (FEV1% and FVC% respectively) and 
dichotomized these into a lower and upper median. Chronic obstructive pulmonary disease 
(COPD) was defined from the spirometric measurements as persons with FEV1/FVC<0.7. 
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4.4 Variables for adjustment 
Blood pressure (BP) was measured using a Mercury Sphygmomanometer, model Mark3, 
designed by Rose, Holland and Crowley 148. Hypertension was defined as a systolic blood 
pressure of 140 mmHg or more, or a diastolic blood pressure above 90 mmHg or more.  
In the 1960s and the 1970s, blood cholesterol and glucose were measured using a 
colorimetric three-channel auto analyser (Technicon AutoAnalyser II). Diabetes was 
defined as either known from an individual’s medical history, or indicated by an incidental 
blood glucose level above 11.0 mmol/l. 
The questionnaires used to assess possible angina pectoris and other chronic disorders were 
based on a combination of the chest pain questionnaire developed by G Rose and used by 
the WHO 149 and forms used by Statistics Norway supplemented with a few questions 
specific to this survey alone. Diagnoses of cardiovascular disease were based on a 
combination of self-reported cardiovascular disease and the interviewing medical officers’ 
conclusions after interviewing the respondents regarding history and symptoms of 
intermittent claudicating, angina pectoris and myocardial infarction.  
Information regarding bronchitis and asthma was obtained from self reports to a 
questionnaire used in standardized interviews. Bronchitis and/or asthma only present before 
15 years of age was defined as childhood asthma/bronchitis (yes/no) and asthma and/or 
bronchitis present after 15 years of age was defined as adult asthma/bronchitis (yes/no). 
Breathlessness was recorded on a scale from 0=no respiratory difficulties to 7= constant 
breathlessness, based on physician-interview-conclusion. We dichotomized the 
breathlessness-information into no (0) and any kind of breathlessness (1).  
Socioeconomic status was categorized into 5 groups according to profession and 
dichotomized into Social class C+D or Blue collar I+II and Social class A+B or White 
collar I+II and ‘others’ (students, housewives, etc). The social status were defined according 
to the standard for grouping of occupations in Norwegian health statistics 99.  
Smoking habits were categorized into 5 groups: never-smokers, former-smokers, smoking 
of pipe/cigars, smoking 1-9 cigarettes per day and smoking ten cigarettes or more per day. 
Smoking was defined as consuming at least one cigarette per day for at least a year. Former 
smokers were defined as those who had stopped smoking at least one month before the 
baseline examination. Smoking of cigars was defined as at least one cigar used per week. 
Smoking of pipe was defined as at least 10 grams of pipe-tobacco used per week.  
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4.5 Mortality Statistics  
Since 1964 all residents of Norway have been assigned a unique 11-digit identification 
number which includes their date of birth. Name, address and identification number are 
registered by the Central Population Register of Statistics Norway, which by law must be 
kept up-to-date regarding deaths and emigration. When a registered Norwegian dies inside 
Norwegian borders, a death certificate is issued by a physician, and sent to Statistics 
Norway. A death registered on the basis of a medical death certificate is matched with the 
corresponding identification number in the Central Population Register. The registered 
underlying cause of death is the disease that initiates the series of events that eventually 
leads to death 212. Statistics Norway used the 7th, 8th, 9th and 10th revision of the International 
Classification of Diseases (ICD) during the study period from 1964 to 2005 (Table 3).  
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Table 3. ICD codes (and corresponding ICD versions) used in Norway during the 
study period covered by the variables Fatal stroke and Coronary death.  
Year of death ICD-version in use Fatal stroke (Eurocode 36) 
Coronary death 
(Eurocode 34) 
1964-68 6/7 330-334 420, 422 
1969-85/86-95 8/9 430-438 410-414
1996-2005 10 I60-I69 I20-I25
 
The causes of death were grouped into the 65 causes in the "European shortlist"(Eurocodes)  
which are used in the European official mortality statistics 48. The analyses were based on 
mortality from ischemic heart disease (Eurocode 34, ICD10 I20-I25) and cerebrovascular 
disease (Eurocode 36, ICD10 I60-69), having been given as the underlying cause of death. 
Statistics Norway has linked information on emigration, time and the underlying cause of 
death from September 1965 until December 2005 (cause specific deaths) and September 
2007 (mortality from any cause) to the database using the National Identity Numbers of all 
the invited subjects.  
4.6 Post mortem examination 
The autopsy assessments of the causes of death in this cohort have previously been 
published 75. Necropsy findings were recorded by means of SNOMED codes. The 
Norwegian SNOMED has been prepared by the Norwegian Pathology Association Code 
and Nomenclature Committee in cooperation with the Competence Center for IT in the 
health and social sector, and is based on the Systematized Nomenclature of Medicine34.  
4.7 Statistics 
4.7.1 Basic statistical terms and Kappa statistics 
In the paper regarding validity of stroke and ischemic heart disease in mortality statistics the 
autopsy-verified cause of death was considered as the “gold standard”. The causes of death 
27 
 
recorded in the mortality statistics and at autopsy were compared and tabulated according to 
the following categories:  
1. True positive: a correct match with the diagnosis from the mortality statistics and at 
autopsy.  
2. Over-diagnosed (false positive): case diagnosed in the mortality statistics but not at 
autopsy. Over-diagnosed (%) is the proportion of false positives divided by all the 
positives according to the mortality statistics (test).   
3. Under-diagnosed (false negative): case diagnosed at autopsy but not in the mortality 
statistics. Under-diagnosed (%) is the proportion of false negative cases divided by 
all the positives according to the autopsy records (truth). 
4. Sensitivity of the diagnosis in mortality statistics was calculated as the proportion of 
true positives divided by all the positives according to autopsy records.  
5. Positive predictive value (PPV) was calculated as the number of true positives 
divided by all the positives according to the mortality statistics.  
6. Overall agreement between the mortality statistics and the autopsy results was 
assessed by Cohen’s kappa and its 95% confidence interval 34.  
Kappa can be interpreted as the proportion of agreement beyond chance, and Cohen’s kappa 
is the most commonly used kappa-type statistic in epidemiological studies 33. We adopted 
the Landis and Koch classification 190, classifying kappa between 0.00 and 0.20 as poor 
agreement; 0.21-0.40 fair agreement; 0.41-0.60 moderate agreement; 0.61-0.80 substantial 
agreement, and 0.81-1.00 almost perfect agreement. 
4.7.2 Descriptive statistical tests 
The descriptive statistics used in the unadjusted, initial, and descriptive analyses (comparing 
groups) are presented below (Table 4).  
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Table 4. Statistical tests used for descriptive and initial analyses (not controlling for 
confounding) 
Exposure variable 
Outcome variable Two independent 
groups              (ex. 
gender) 
Three or more independent 
groups     (ex. age-range, PA-
levels, BMI-range) 
Dichotomous                        
(ex. autopsy, participation) 
chi-square or Fisher’s 
exact test 
chi-square or Fisher’s exact test 
Ordered categorical            
(ex. BMI-range or 
smoking habits) 
Wilcoxon-Mann-
Whitney (WMW) test 
Kruskal-Wallis analysis of 
variance (ANOVA) 
Continuous (normally 
distributed)                            
(ex. s-cholesterol, follow-
up time*) 
independent sample T 
test 
one-way ANOVA 
Censored: time to event      
(ex. survival) 
log-rank test (Kaplan 
Meier) 
log-rank test (Kaplan Meier) 
* including the deceased only 
Chi-square tests and T-tests tests were used when appropriate. We used one-way ANOVA 
to test for both linear and quadratic trends in the association between follow-up time and 
BMI-range for the three different age-ranges. Kaplan Meier plots and log-rank tests were 
performed for upper/lower median of lung function, and for categories of BMI and levels of 
physical activity.  
4.7.3 Logistic regression 
Logistic regression was used in the paper regarding validity of cerebral stroke and ischemic 
heart disease in mortality statistics. This statistical method predicts the probability of a 
binary outcome (ex. referral for post mortem examination (yes/no)) in relation to several 
prognostic variables. The logistic regression model expresses the outcome as a combination 
of the explanatory variables (predictors) that may be either numerical or categorical. p is the 
probability of the binary outcomes being equal to one. The logit-transform log(p/(1-p)) is 
expressed by: b0 + b1x1 + b2x2 +....bkxk where b0 is the intercept, and the other b’s are the 
regression coefficients and k is the number of variables in the model. Odds ratio for each 
variable can be calculated from the regression coefficients 8. 
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4.7.4 Survival analyses and proportional hazard assumption 
In contrast to logistic regression survival analyses handle censored data vs events. 
Censoring occurs when a person is still alive when he/she is lost-to-follow-up or when the 
study ends. In both cases the time followed until censoring will contribute to the results of 
the calculations. The survival analyses used in this thesis were based on survival tables, 
Kaplan-Meier plots, log-rank tests and Cox proportional hazard models with years of follow 
up as the underlying time axis. Survival models relate the time that passes before some 
event occurs to one or more covariates that may be associated with that outcome of interest 
(ex. death). Cox proportional hazard regression method is useful in discriminating between 
several simultaneous effects of different risk factors (explanatory covariates) over time. The 
Cox model consists of: the underlying hazard function, often denoted H0(t), describing how 
the hazard (risk) changes over time at baseline levels of covariates; and the effect 
parameters, describing how the hazard varies in response to explanatory covariates. The 
hazard function for the Cox proportional hazard model is expressed as:  
H(tX) =H0(t)·exp(1x1+ 2x2 + 3x3... kxk) 
A strong assumption is made that effects of the different variables on survival are constant 
over time and log-linear (additive). For categorical explanatory covariates like BMI-ranges 
or PA-levels, the assumption of proportional hazards was evaluated by visualizing log(-log) 
plots (or log minus log; LML) 166. We can do this in SPSS by putting the covariate that we 
want to test in the Cox model as stratum variable, not as covariate (one at a time.) Tick 
LML plot in the Plot sub-dialog. The lines should be parallel if the assumption of 
proportional hazards is met. 
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Figure 3. LML plot of strata for BMI (all age-ranges combined) against time of follow-up 
 
 
As we can see in Figure 3 the line representing the lowest BMI-range (<22) crosses the line 
of the reference-range (22-25), but the lines are tolerably parallel before 10 years of follow 
up and beyond 20 years of follow-up. We also eliminated the participants who died within 
the first 72, 100 and 200 months of the follow-up time and it did not change the size or 
direction of the effect estimate (hazard ratio) associated with the lower BMI-range. As we 
can see the lines in Figure 4 are parallel over time for the different levels of physical 
activity. 
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Figure 4. LML plot of strata for 3 levels of LPA (PA2) against time of follow-up 
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For continous explanatory variables (like FEV1) the assumption of proportional hazards was 
evaluated by plotting Schoenfeld residuals 162 (Partial Residuals) against time. We can do 
this by ticking them in the Save sub-dialog when we are conducting a Cox analysis. A 
residual variable will be created for each covariate. Then we plot each residual variable 
against time and there should be no trend if the assumption holds (Figure 5). These residuals 
are computed only for cases with event (i.e., non-censored). 
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Figure 5. Plot of partial residuals for FEV1 against time of follow-up for cases of death 
due to cerebral stroke. 
As we can see from Figure 5 there is no trend over the follow-up time. 
 
We explored associations to possible confounders and intermediate variables, and effect 
modification by both stratified analyses, use of interaction terms and bivariate/multivariate 
adjustments. Variables that changed the effect estimate of interest with more than 10% were 
included in the model.150 
 
In the paper regarding age, physical activity and mortality, the population attributable 
fraction (PAF) was calculated for each of the risk factors included in the multivariate 
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analysis for the three different age ranges (20-44, 45-64, 65+) separately. PAF expresses the 
reduction in events when a risk factor is removed from a population. In contrast to a relative 
risk (RR), the PAF also involves the prevalence (p) of a risk factor in the population: 
PAF=p(RR-1)/(1+p(RR-1)). In survival analyses, when the outcome is not only RR, but a 
function of time (HR), the PAF expresses that part of mortality attributable to a risk factor in 
a given time-interval t, but it might be easier to think of PAF as ‘attributable shortening of 
longevity’. 95% confidence intervals of the PAFs were computed according to a 
bootstrapping approach 158. 
In the paper regarding the association between lung function and risk of stroke the model fit 
of the two different measures of lung function (FEV1 at baseline and FEV1 decrease over 
time) were compared using likelihood ratio test (part of the output from a Cox algorithm in 
SPSS). Likelihood ratio test compares the fit of two models, one of which (the null model) 
is a special case of the other (the alternative model). A greater log-likelihood means a better 
model fit 204.  
4.7.5 Bias reduction 
To assess possible bias from under-nutrition, inactivity or poor lung function due to a pre-
existing illness at baseline (reverse causation), the deaths that occurred in the initial six 
years (72 months) of the follow-up period were excluded from the preliminary analyses 66.  
All analyses were performed using SPSS software, version 15.0 and Microsoft Office Excel 
2007. 
4.8 Ethical considerations 
These data are anonymous, unidentifiable and confidential; their use in this study is by 
permission granted by The Data Inspectorate and the Norwegian Directorate of Health and 
Social Sciences. The participants volunteered to attend the survey examinations after having 
received a written, informational letter. At baseline in 1965-71 they gave informed, oral 
consent to have their data recorded for observational research (Sulheim O., personal 
communication, 2010).  
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5 Results 
We tested BMI, PA, and FEV1 as markers of ageing in different ways and we also explored 
predictors of autopsy. As an overview these key variables are presented in Table 1 as an 
introduction to the following sections. We have parted the population into those study 
subjects dying before reaching the age of 80 years and those surviving until 80 years or 
above for illustrative means. 80 years was the 75 percentile of age at death for men, whereas 
85 years was the 75 percentile for women.  
 
Table 5.  Characteristics in 5040 participants of the Bergen Clinical Blood Pressure 
Survey followed until 2005-7 with valid data for all the explanatory 
variables explored in this thesis (BMI, PA and FEV1), and with death 
before the age of 80 years or survival until 80 years or beyond. 
Attained age at the end of follow-up 
Characteristics  < 80 years 
N (%) 
 80 years 
N (%) 
p-value 
Male 1659 (71) 681 (29) Sex 
Female 1273 (47) 1427 (53) 
<0.001 
 
Autopsy Yes 930 (83) 184 (17) <0.001 
<22 kg/m2 522 (62) 325 (38) 
22-24.9 kg/m2 777 (54) 651 (46) 
25-27.9 kg/m2 623 (55) 520 (45) 
BMI 
28+ kg/m2 438 (57) 329 (43) 
0.001 
No  622 (62) 387 (38) PA 
Yes (any) 1741 (54) 1501 (46) 
<0.001 
Lower median 1462 (62) 909 (38) FEV1% 
Upper median 875 (47) 972 (53) 
<0.001 
Abbreviations: BMI: Body Mass Index; PA: Physical Activity (defined as regular engagement in any of 6 listed activities); FEV1%: 
Forced Expiratory Volume after one second as a percentage of a predicted value, divided by the median=107. 
35 
 
5.1 Synopsis of papers 
5.1.1 Paper 1: Endpoint ascertainment 
Title: “Diagnostic Validity of Fatal Cerebral Strokes and Coronary Deaths in Mortality 
Statistics: An Autopsy Study” 
 1,140 (26%) of those invited to the study and who died during follow-up were examined by 
autopsy at the Gade Institute. The ratio of autopsies to the number of deaths decreased from 
40% in the period 1964-75 to 11% in the period 1995-2005. 
Only 742 (65%) of the autopsy-reports were forwarded and/or recorded in the mortality 
statistics 
The validity of fatal cerebral strokes and coronary deaths reported as the underlying cause 
of death in mortality statistics for this cohort had a Cohen’s kappa coefficient of 0.79 and 
0.80, sensitivity of 0.75 and 0.88, and a positive predictive value of 0.87 and 0.86 
respectively when compared with autopsy findings. These findings show substantial 
agreement between cause of death from autopsy findings and mortality statistics.  
The kappa coefficients for the fatal stroke diagnoses calculated for the 4 different quartiles 
of the follow-up period (before 1978, 1978-1986, 1987-1995, 1996-2005) were 0.83, 0.77, 
0.70, and 0.85 respectively, showing no trend of increasing diagnostic validity over time. 
For coronary deaths the corresponding kappa coefficients were 0.81, 0.79, 0.81, and 0.83, 
respectively. 
Death from cerebral stroke was a negative predictor of referral for autopsy, whereas death 
from coronary heart disease was not, both adjusted for sex, period of death and age at death. 
Female sex was also a negative predictor of autopsy. 
5.1.2 Paper 2: Body mass and all-cause mortality in different age-ranges 
Title: “Increased mortality in the slim elderly. A 42 year follow-up study in a general 
population”
In all, only 3.2 % of the elderly participants (2.9 % of the women and 3.6 % of the men) had 
a BMI below 18.5 kg/m2. 17 % (15% of the women and 19% of the men) had a BMI less 
than 22.0 kg/m2.  
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The 20 years cumulative risk of death related to baseline BMI was U-shaped in the elderly 
(aged 65–75 years), whereas the pattern was more linear in the youngest age group (20–44 
years). The hazard ratio of death during the follow-up was calculated for three age ranges. 
Adjustments were made to age and sex (Model 1) and multiple variables (Model 2). The 
calculations were also made stratified to sex. In contrast to the younger age groups, the 
highest mortality in the elderly was in the lower BMI range (<22.0 kg/m2) (adjusted Cox 
proportional Hazard Ratio 1.39, 95% Confidence Interval 1.10, 1.75) compared to the BMI 
reference group (22.0–24.9 kg/m2). 
 
To address reverse causation bias we calculated the hazard ratio of death for the oldest age 
category (65+) with a BMI less than 22.0 kg/m2 by selectively including participants who 
had survived a stepwise increasing number of months of early follow up. The crude hazard 
ratio of death related to the lowest BMI-group in the elderly, compared to the BMI-
reference range (22.0-24.9), declined from a HR of 1.41 95% CI [1.13, 1.75] when all cases 
were included to 1.36 [1.06, 1.74] when we included only events for subjects who had 
survived more than 72 months of follow up. With further elimination of follow-up years the 
effect estimate remained in the same order of magnitude, but the confidence interval 
broadened due to decreasing sample size. For example, by eliminating 100 and 200 months 
of early follow up events, the HR became 1.30 [0.99, 1.69] and 1.45 [0.99, 2.12] 
respectively.  
The predictive power of BMI was compared to the other anthropometric measure and the 
hazard ratios associated with the three upper quartiles (reference lowest quartile) of the 
other available anthropometric measures (skin fold thickness and triceps circumference) 
were smaller than the hazards associated with quartiles of BMI (HR BMI quartiles 2-4 
relative to 1: 1.15, 1.61, 2.28, with quartiles of skinfold thickness subscapular 
region:1.24,1.51, 2.23, with quartiles of skinfold thickness triceps: 0.87, 0.84, 1.05 n.s., and 
with quartiles of triceps circumference: 1.15, 1.30, 1.48). The model also fitted slightly 
better with the BMI measurement (-2 log likelihood test 166). Smoking and preexisting 
disease is assumed to be of the most important confounders in the association between a low 
BMI and the higher risk of death. The HR did not change significantly in any of the age 
segments after adjusting for smoking or in any of the subgroup-analyses performed (never-
smokers, survivors of more than 72 months of follow up, and those without recognized 
obstructive lung disease or cardiovascular disease). 
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5.1.3 Paper 3: Physical activity and mortality in different age-ranges. 
Title: “Ageing, physical activity and mortality – a 42-year follow-up study” 
Men reported higher levels of physical activity than women did, and we found a positive 
trend towards higher levels of physical activity in men among all age groups. The number of 
participants reporting no engagement in any of the listed activities were 305 (39%), 579 
(23%), and 402 (18%) in the old, middle-aged and younger adults respectively. 1754 
participants reported that their activity level had decreased the last five years. Out of these 
349 (20%) reported that the cause of change was disease. The majority (80%) reported it to 
be lack of interest or lack of time because of workload or children.  
The HR(95%CI) associated with the highest level of physical activity was 0.63(0.56-0.71), 
0.66(0.52-0.83) and 0.66(0.47-0.93) for mortality from all-causes, ischemic heart disease 
and stroke respectively compared to the group reporting no/low activity and adjusted for age 
and gender. For the moderately active participants the corresponding HRs were 0.75(0.69-
0.81), 0.77(0.66-0.90) and 0.83(0.67-1.03) respectively. 
Stratified analyses were successively carried out for all subgroups of the following variables 
for adjustment: gender, hypertension, cholesterol>median (yes/no), diabetes (yes/no), 
smoking status, BMI-range, socioeconomic status (poor = Blue collar)/good = White 
collar/others), pre-existing IHD, FEV1%<median (yes/no). The analyses demonstrated a 
favorable effect of high physical activity compared to low physical activity in all strata of all 
these variables.  
For the multivariate assessment, we amalgamated the PA measure into a dichotomous 
variable. Each of the selected modifiable risk factors was examined for their association to 
all-cause mortality adjusting for age and gender only. The inverse association between PA 
and all-cause mortality persisted after the elimination of deaths occurring in the first 72 
months of the follow-up period (HR 0.67(0.56-0.79), p<0.001, 0.74(0.68-0.83), p <0.001 
and 0.80(0.69-0.95), p 0.009, in the young, middle-aged and old respectively, all, adjusted 
for age and gender). We observed the same trend in a subgroup of participants without 
hypertension, diabetes, and ischemic heart disease (HR 0.64(0.54-0.77), p<0.001, 0.77(0.67-
0.88), p<0.001 and 0.66(0.48-0.92, p0.013, in the young, middle-aged and old respectively, 
all adjusted for age and gender). The findings also seemed unaffected by exclusion of the 
participants who reported that they had changed their activity level due to disease in the 5 
years preceding the baseline examination (HR 0.69(0.58-0.81), p<0.001, 0.77(0.70-0.85), 
p<0.001 and 0.79(0.68-0.93), p 0.004, in the young, middle-aged and old respectively, all 
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adjusted for age and gender).  The final multivariate analysis was carried out to compare the 
effect of PA to other known risk factors of death. PA was associated with a 22-24 per cent 
lower risk of death in all three age-ranges compared to those who reported no participation 
in the listed activities. The association between physical activity and mortality was stable 
across the age ranges whereas the risks associated with smoking, diabetes, hypertension, and 
possibly overweight seemed to be less prominent in the old compared to younger age-
groups. A low total cholesterol level and underweight were associated with increased 
mortality in the old in contrast to the younger age ranges. 
Finally, the population attributable fraction (PAF) adjusted to age and gender was calculated 
for each of the risk factors for the three different age ranges separately. Multiadjusted 
calculations were also performed, but did not change the results. The leading risk factors 
contributing to PAF of mortality from all causes for the older subgroup were hypertension 
(18.9%), lack of participation in any of the listed activities (9.1%) and a low BMI (<22 
kg/m2) or a high BMI (28 kg/m2) (5.8 and 6.0 % respectively). For the middle aged, the 
leading risk factors were hypertension (16.2%), smoking (10.0%), and lack of participation 
in any of the listed activities (7.7%). In the younger adult age-segment the leading risk 
factors were smoking (19.9%), s-cholesterol above the median (6.69 mmol/l) (11.5%), and 
lack of participation in any of the listed activities (7.3%).  
5.1.4 Paper 4: Lung function and mortality from stroke 
Title: The association between lung function and fatal stroke in a community followed for 
four decades.”
The inverse association between stroke and level of FEV1 was calculated separately for men 
and women using Cox proportional hazard regression models with progressive adjustments 
for age, sex, body height and different potential confounders 65. Age, body height and sex 
are the variables included in the standard prediction models of both FEV1 and FVC 91 and 
their influences on the association between FEV1 and risk of fatal stroke was HR(95%CI): 
2.6(2.3-2.9), unadjusted; 3.3(2.9-3.8), height-adjusted only; 1.1(1.0-1.3), age-adjusted only; 
3.5(3.1-3.9), sex-adjusted only. These variables were included for adjustments due to 
common practice despite the minor influence from body height. After adjustments to these 3 
variables the other confounding variables changed the FEV1-related hazard ratio for a fatal 
stroke less than 10 percent and thus were not included in the main analyses. Since the age-
adjustment resulted in a marked drop in the HR for FEV1, we also studied the lung-stroke 
39 
 
association in different strata of age at baseline (tertiles). The overlapping 95% confidence 
intervals of these analyses indicated non-significant differences in the association between 
FEV1 and the risk of stroke with increasing age (HR(95%CI) of fatal stroke associated with 
FEV1 was 2.41(1.18-4.91) in age-range <40 years, and 1.41(1.14-1.77) in age-range 56+ 
years at baseline, adjusted for sex, age and height. The hazard ratios of the FEV1*age and 
FEV1*sex interaction terms tested separately in the main model were 1.00(0.99-1.01) and 
1.02(0.78-1.33) respectively. 
Previous studies have shown that the impact of risk factors may differ between successive 
time periods 72. We calculated the hazard related to the early (0-19) years and the late (20-
40) years of the follow-up period and found that these were comparable. 
The calculations of the main model (adjustments for sex, age, height) were also carried out 
in a subgroup of lifetime non-smokers (n=2317), in order to eliminate potentially 
unrecognized residual confounding from smoking, resulting in a HR(95%CI) of 1.88(1.39-
2.55) per liter lower level in FEV1. When we did subgroup analyses of the main model in 
participants without breathlessness (n=4366) the HR(95%CI) was 1.47(1.16-1.86) per liter 
lower level in FEV1. This was done in order to investigate whether the lung-function 
measurement would add information to stroke risk assessment in subjects free from 
respiratory symptoms. Finally we did subgroup analyses of the main model in participants 
without diabetes, hypertension and a medical history suggesting atherosclerotic symptoms 
(angina pectoris, intermittent claudicating or myocardial infarction) at baseline (n=3507), 
HR(95%CI) 1.43(1.07-1.90). This was done in order to assess whether the relationship 
between poor lung function and the risk of stroke precedes the presence of atherosclerotic 
disease. The hazard ratios associated with FEV1 remained remarkably stable irrespective of 
the subgroups studied. 
A multiple regression analysis was finally carried out to illustrate that none of the 
confounding factors reported in other research could explain the association of interest.  
To minimize any bias from pre-clinical disease prior to baseline that could possibly lead to 
both reduced lung function and increased mortality from stroke, we performed a sensitivity 
(robustness) analysis where events from the first 5 years of the follow-up period were 
excluded. This changed the hazard ratio(95% CI), associated with one litre lower level in 
FEV1 across baseline data, from 1.38(1.11-1.71) to 1.30(1.02-1.66) and from 1.62(1.22-
2.15) to 1.61(1.20-2.15) for men and women respectively, indicating that this type of bias 
has not affected the results.  
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Previous studies have shown that the impact of risk factors may differ between successive 
time periods. 72 We calculated the hazard related to the early (0-19 years) and the late (20-40 
years) of the follow-up period and found that these were comparable. 
Finally we explored the association between FEV1 and stroke-risk, after adjustments for 
changes in lung function during adult life. The final analyses were performed on a subgroup 
of 953 men who had recordings on FEV1 at both baseline and the follow-up examination in 
1988-90. The mean FEV1(SD) at baseline in this subgroup was 4.42 (0.83) litres. The mean 
decline in lung function per year between the baseline examination and the follow-up 
examination in 1988-90 was 53 (19) ml/year. Of the 953 men who had complete sets of data 
on FEV1 both at baseline and in 1988-90, 23 fatal strokes were recorded in the mortality 
statistics in the follow-up period running from the second FEV1 measurement (1988-90) 
until end of follow-up (2005). The association between the two different lung function 
measures and fatal stroke was explored using four different models. Model 1: unadjusted, 
Model 2: including only baseline FEV1, age, and body height, Model 3: including only 
change in FEV1 per year between baseline and the follow-up survey in 1988-90, age, and 
body height, and Model 4: including both baseline FEV1, change in FEV1 per year between 
baseline and the follow-up survey in 1988-90, age, and body height. We found a better 
model fit with the baseline level of lung function than with the change in FEV1 (-2 log 
likelihood test).  
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6 Discussion 
6.1 Methodological considerations 
6.1.1 Study design 
A major asset of prospective studies is that the exposure of interest is measured and 
recorded before the outcome 1. Strengths of this study are the very long follow-up period, 
the high participation rate, and inclusion of both sex from a general population and the 
access to an extensive array of possible confounders for each of the study participants. A 
possible weakness is the observational character of the study (in contrast to a randomized 
controlled trial) and that it was not initially designed to study elderly people specifically. 
6.1.2 Bias 
The sampling and attendance rate of a study are possible sources of selection bias 1;8. Our 
cohort was randomly selected from a general adult population of both sexes, without any 
selection due to occupation, and with an extraordinarily high participation (84%). Some of 
the previously reported studies on this topic have been made on health personnel 5;13;113, 
assumed to be more concerned about health issues than the general population. Participation 
in previously reported population based studies in this field has varied from 46% to 72% 195. 
The baseline characteristics of non-participants versus participants were compared. The 
proportion of participants was slightly higher in the middle-aged female category. The 
mortality was higher among the non-participating men compared to the participating men 
during the follow up period (Odds ratio (OR) 2.10, 95% Confidence Interval (CI):1.56, 2.83, 
adjusted for age at baseline). For women there was no statistically significant difference 
regarding mortality related to participation (OR 1.27, 95% CI 0.94, 1.71). Non-participants 
died at younger age for both sexes. The mean number of years lost for non-participants 
compared to participants was 4.7 for men and 2.7 for women. (P<0.001, Fisher exact test).  
Despite the high attendance rate at the initial survey in 1965-71 (84%), all the participants 
had to be capable of attending the clinic in person. Frail and ill members of the target 
population are therefore likely to be underrepresented. This selection is, however, more 
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likely to minimize than exaggerate the inverse association between BMI, level of physical 
activity, lung function and the fatal outcomes (“healthy participant effect”).  
A higher body mass, physical activity and a better lung function is more feasible in the 
absence of disease, and bias from reverse causation (pre-terminal illness as the cause of 
underweight, inactivity and poor lung function) may explain some of the findings. We 
limited bias from reverse causation by excluding the initial 72 months of early follow-up 
deaths in the preliminary analyses, but this did not change the finding. 
Self-reporting is a common means of collecting data in other studies 178, and recall bias 
regarding body mass has been shown to increase with increasing body weight and age 
152;179.  We have objective measurements of BMI and FEV1 in contrast to self-report on 
height/weight and respiratory symptoms used in many other studies. The questions 
regarding physical activity during the past 5 years before baseline are based on validated 
questionnaires and used in other studies, but the records may still be biased. We do not 
know if there for instance is over-reporting of physical activity among the participants in the 
upper body mass ranges due to bad conscience.  
6.1.3 Confounding 
Confounding variables are associated with both the exposure and the outcome and can affect 
the strength of the effect estimates in the calculations 1. Confounding is explored in the 
following way: 1) Biological plausibility: We include variables which seem reasonable to 
influence the association between an exposure variable of interest and the outcome. 2) 
Mechanical/statistical approach: We include variables on a threshold level of effect (for 
instance 10%) on the association of interest. A combination of these approaches seems 
justifiable. Unrecorded socioeconomic factors like education, diet, alcohol consumption, 
intensity/duration of physical activity might have influenced our results slightly, but 
information on these variables were not available to us. 
The study population was less exposed to pharmaceutical and medical intervention 
strategies (due to changes in medical standards in the 1960s) than the population is today. 
For instance only 78(1.5%) of our cohort used antihypertensive drugs at baseline. 
Systematic guidelines for antihypertensive therapy was introduced after 1978 197and statins 
were introduced after 1994 155. This may have contributed to reduce the presence of bias and 
confounding in the association between physical activity and mortality.  
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6.1.4 Reliability 
-describes the accuracy and precision of a test or measurement and its capacity to produce the 
same results when applied repeatedly under the same conditions.  
The most important tools used in this thesis are the measurements of blood pressure, 
spirometric measurements, blood-sample analyses, body height and weight, and the 
questionnaire. These methods have been used in numerous previous studies referred to in 
the respective papers of this thesis.  
The physical activity measure used in paper 3 is crude. There is a possibility of 
measurement error or misclassification to activity levels. The 6 questions regarding physical 
activity can miss some types of activity. For instance are household-activities not mentioned 
in the questionnaire. The participants may have interpreted the various terms differently, for 
instance “regular exercise”. The intensity and duration of the activities is unknown and may 
have varied extensively between individuals assigned to the same PA-level. It is possible 
that these errors may be differential by gender as well as by age-range and socioeconomic 
group. Misclassification will rather minimize than exaggerate the findings of a beneficial 
association between PA and survival.
6.1.5 Validity 
A measurement with high validity collects findings/interpretation of such which are close to 
the truth. 
Internal validity is the ability to control for variables other than the dependent one. When the 
researcher may confidently rule out other explanations and attribute the observed changes or 
differences in the dependent variable to the independent variable, then his causal inference 
is said to be internally valid. Unrecognized confounding, systematic errors, biases and the 
reliability of the measurements used could distort the internal validity. The validity of the 
fatal endpoints has been investigated in a previous publication, and found to be in marked 
agreement with autopsy findings 64.  
External validity refers to the generalizability of the study – to what extent the results of the 
study are applicable to people not in it. Internal validity is necessary for external validity. 
The representativity of the study sample for the reference population is also necessary for 
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external validity. When findings are consistent across different populations it supports 
external validity.  
Patient populations selected from clinical settings are quite different from samples drawn 
from the general population 128. Patients seeking medical supervision are likely to have 
more symptoms and comorbidities than subjects not seeking medical care.  
Of the 6,738 eligible subjects for the clinical survey, 2,534 (83%) men and 3,119 (84%) 
women participated in the study. The clinical characteristics of the study population 
generally resembles those found in the county services in the 1970-ties 22.  
Our findings could also be valid in 2011 taking into account the following: a) Differences 
due to treatment-effect. The study population used a limited number of drugs (only 10%, 
18% and 23% of the young, middle-aged and elderly respectively used one or more drugs) 
so the influence of medical treatment upon the effect-estimates is assumed to be limited 
compared to studies conducted today. b) A possible effect-modification due to weight-gain 
after smoking cession (which is less harmful than continuing smoking and staying slim) and 
the fact that there are less smoking men and more smoking women today.  c) The beneficial 
effect of increased physical activity may be superior to the possible adverse effects of 
overweight. However, considering our analyses of the non-responders, the validity of the 
methods used, the exploration for reverse causality and the knowledge that the human 
physiology has stayed remarkably unchanged over many years, we believe we have enough 
evidence to say that our major conclusions hold also external validity for individuals at age 
20-79 years of today, living in Norway. 
6.1.6 Causality 
Our findings are observational. It is still tempting to address the Bradford Hill arguments of 
causation 80 and suggest that there is a causal link between body mass, physical activity, 
lung function, and mortality. The strength of the associations, consistency, temporality, 
coherence and biologic plausibility enable us to draw such a conclusion.  
6.1.7 Long term-follow up and time-dependent covariates 
The presence of all modifiable risk factors may change over time and physical activity is no 
exception 78;181. Long-term follow-up and the influence of time dependent covariates have 
been discussed in previous publications 93. Previous evidence suggests that the lack of 
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repeated measures of PA during follow up may result in under-estimating the strength of its 
association with mortality up to 60 % 9. Our findings represent therefore a conservative 
estimate of the association between PA and mortality. 
6.1.8 Stroke incidence vs. stroke mortality 
Previous studies have compared risk factors for stroke incidence and stroke mortality 71;73. 
These have concluded that studies with information on stroke mortality are likely to give 
results applicable to stroke incidence. Stroke mortality is however a more severe event than 
stroke incidence. Concomitant co-morbidities may be one explanation for incidence versus 
mortality of stroke. 
6.1.9 Summary 
The study was conducted in a random general population sample. Standardized methods, 
validated tools, and analytic techniques controlling for confounding were used. The external 
validity of the findings was further strengthened by the age span and by the comparable 
clinical characteristics of other cohorts from the same time period in Norway 22. 
 
6.2 Discussion of the main results 
6.2.1 Validity of fatal stroke and coronary deaths in mortality statistics 
Our study indicates that the validity of fatal cerebral stroke as well as that of coronary death 
in the Norwegian mortality statistics for the city of Bergen seems to be satisfactory. The 
kappa coefficients, sensitivity and positive predictive values range between 0.71 and 0.92. 
Our findings are largely supported by the limited number of previous studies in this area 
143;153;172. Forty years ago a Norwegian study based on autopsy records 192  also concluded 
that the over-all figures for stroke deaths are generally reliable in the mortality statistics.  
The kappa coefficient of both the diagnoses fatal stroke and ischemic heart disease in the 
mortality statistics did not change significantly during the study period or across the 
different ICD versions in use (results not shown). This is somewhat surprising, as we have 
experienced an increased access to more advanced diagnostic procedures over the last 
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decades, improving the accuracy of both diagnoses in general. The fatal strokes may be 
clinically more obvious than the non-fatal strokes and the diagnostic accuracy of these cases 
may thereby be less influenced by the increasing access to advanced technology. While the 
disagreement between autopsy results and clinical diagnoses remains fairly stable 61, the 
number of post mortem examinations decreases. This may well result in an increase in 
diagnostic errors in the future, as this quality control is lost for the clinical work of 
physicians.  
We found limited differences in the accuracy of the mortality statistics according to whether 
the diagnoses were autopsy-based or not. The value of an autopsy is only adequately 
exploited if the results are correctly incorporated into mortality statistics. In previous studies 
up to 40% of autopsied cases were not properly reported in mortality statistics 44;53. 
Fatal stroke, increasing age and female sex are negative predictors of post mortem 
examination, whereas coronary deaths are not, which agrees with the findings of a Finnish 
study 104. It has previously been shown that the location where death takes place also 
contributes to the demand for autopsy (hospital deaths are examined much more often than 
nursing home deaths and death in surgical wards more often than deaths in medical wards). 
Furthermore, more uncertain clinical diagnoses tend to be selected for autopsy and the 
pathologists tend to favor the more unusual diagnostic groups 75;95. 
6.2.2 BMI and mortality 
This study shows that in elderly people (65+) a BMI less than 22 kg/m2 are an appreciable 
independent predictor of death. For a general population, BMI tends to increase during the 
first period of adulthood and decrease after the age of 65 145;207. Despite the large sample 
sizes of previous studies, the trends of association between BMI and all-cause mortality 
remain uncertain for the older age-segments 13;27;45;49;113. In our study, the trend turned from 
almost linear in the younger age group, through J-shaped in the middle aged to U-shaped in 
the elderly. The shapes of the curves are comparable for the two sexes, especially in the 
elderly group, indicating minor risk of effect modification due to sex. The upper BMI-
values seemed to be associated with an increased risk of death in all age ranges, but in the 
elderly the lower BMI-range, i.e. <22.0 kg/m2 was more hazardous than belonging to those 
above 28.0 kg/m2.  
Moreover, the association could not be explained by preclinical disease at baseline or 
confounding factors, especially not former or current smoking, indicating that low BMI is 
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an independent risk factor among subjects aged 65 or older.  The methods used to minimize 
bias from underweight caused by preclinical disease (reverse causation) vary between 
different research groups. Exclusion of early mortality is one approach, but there is no 
consensus as to how many years of follow up should be excluded 38;77. Some investigators 
eliminate no deaths; some have suggested eliminating the first four years of death while 
others have recommended eliminating all individuals with any kind of weight loss before 
baseline. Effects from obesity, including hypertension, glucose intolerance and 
hypercholesterolemia, are considered as links in the causal pathway by which obesity 
influences mortality risk. It has been reported that the “independent” or residual effect of 
obesity on mortality is clinically non-relevant 112. The causal pathway may not be that 
obvious with regard to the association between the lower BMI-segment and risk of death, 
except from confounding from smoking and bias from sub clinical disease. Restricting the 
analyses to never-smokers and eliminating the first 72 months of follow up showed only a 
limited effect from these two potential sources of bias. The crude HR was reduced from 
1.41 to 1.34 in the elderly with BMI less than 22 kg/m2. Hence it seems reasonable that the 
higher risk associated with low BMI in the elderly is due to causes other than bias from 
reverse causation. The effect persisted throughout the follow-up period; at its end, all of the 
elderly participants had died.  
In the elderly, an increased risk of osteoporosis and lack of nutritional reserves to survive 
acute illness has been highlighted as contributory mechanisms for the increased risk of death 
in the lower BMI-ranges 12;140. As senescence and degenerative diseases cause loss of 
weight, a higher weight may extend life by offering increased reserves. Studies have shown 
that subjects with low BMI have increased risk of falling 191, fracture 62, cardiovascular 
complications after hip fracture repair 14, and they suffer more severe outcomes of various 
chronic disease, like chronic obstructive lung diseases 163 and stroke 114. These all are 
mechanisms that might help explain the association between thinness and increased 
mortality in the elderly.  
It is often assumed that any associations between BMI and mortality are due to the 
accumulation of adipose tissue, whether overall adiposity or site-specific adiposity 50.  Body 
composition changes with increasing age towards an increasing fat/muscle mass ratio. In the 
upper BMI-ranges the fat/muscle ratio might potentially confound the association towards a 
higher risk in the sarcopenic obesity 199. The percentage of body fat and BMI is quite well 
correlated in major parts of the BMI-range, but excess body fat storage (body fat %) trails 
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off with increasing BMI 102. In our study 92% of the participants had a BMI less than 30 
kg/m2 leaving obesity of any kind a minor issue. Therefore in our study BMI might capture 
both sarcopenia and central obesity, unhealthy conditions in which the other anthropometric 
measures may be in the normal range. This may be why BMI showed the single most robust 
association to all-cause mortality. 
6.2.3 Physical activity and mortality 
This study demonstrates a long-lasting inverse association between physical activity and 
mortality from all causes, fatal strokes and coronary deaths in a general population. 
Stratified analyses indicated beneficial inverse associations in all subgroups of the study 
cohort and robustness to comprehensive adjustments. The results are comparable to findings 
in most other studies both nationally and internationally 15;20;106;134. In contrast to others, we 
have also found that the associations persisted throughout the entire 42-year follow-up 
period, thus indicating the strength of this predictor. 
Our results also indicate that the association between physical activity and mortality is 
consistent across all age-groups, and independent of age at baseline, which is in contrast to 
the findings for most of the other risk factors. The mortality-sparing effect of leisure-time 
physical activity has previously been reported to be especially visible among the old18. The 
apparent inverse association between total cholesterol and all-cause mortality in the old 
compared to younger individuals has been discussed in previous publications. A possible 
explanation may be that chronic or terminal illness (more prevalent in the old age-segment) 
is associated with a low total-cholesterol, especially in elderly not treated with statins as in 
this cohort137.   
In the younger age range (20-44 yrs), there was a positive ‘dose-response’ association 
between level of physical activity and survival. In another early cohort including middle-
aged men only, health outcomes was associated with vigorous physical activity, but not with 
total activity 29. This may be due to a more limited follow-up time or to methodological 
differences. In the oldest (65+) group in our material, the survival difference associated with 
the highest level of PA was between the levels of no exercise at all and that of any kind of 
activity. This may be due to limited statistical power for the upper PA-level or it could 
indicate that there exists a threshold for the beneficial effect of physical activity in the old. 
A previous study reported that the small differences found between moderate and highly 
active individuals could be related  to the wording of the questionnaire 10. 
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A more recent Finnish study of men and women aged 35-63 found a higher participation in 
vigorous (high) levels of non-occupational PA than we found in our study 70. This might be 
due to a lager load of physical activity at work in the past (and thus less time/energy to be 
physically active beside work), but it may also be due to time-trends, differences in the 
definitions and grouping of PA, selection bias (exclusion of 35% in the Finnish cohort), and 
national differences. Unfortunately, we can neither address time-trends nor compare our 
findings with the findings from other countries (like Finland). 
 
6.2.4 Lung function and mortality 
We found a robust and long-lasting association between lung function and fatal stroke in 
both men and women. Our study adds further information on this issue because of the very 
long and complete follow-up period, high response rate, adjustments for a wide range of 
possible confounding factors, the minimization of bias from ill-health, and the subgroup 
analyses that show robust, persistent, associations also in lifetime non-smokers, in 
participants reporting no respiratory difficulties and in those who had no signs of 
atherosclerosis at baseline.  
Our analyses shed light on some possible explanations for the association between lung 
function and the risk of vascular events. The results weigh against a hypothesis that reduced 
FEV1 may serve as an epiphenomenon for a common environmental offending factor that 
affects both the pulmonary and the vascular systems, as adjustments for the available, 
possible confounding factors and ill-health bias resulted only in minor changes on the risk 
estimates associated with FEV1.  
Another possible explanation for the association is that an inflammatory link exists between 
lung processes and cardiovascular disease. Inducing airway inflammation in rabbits can 
incite and propagate systemic inflammation, which in turn may contribute to the progression 
of atherosclerosis 183. Low-grade systemic inflammation is a major risk factor for plaque 
genesis, progression and rupture206 and might be a target for the possible pleiotropic effects 
of statins136.  FEV1 is known to be associated with carotid artery intimae-medial thickness 43 
and is possibly a marker for smooth muscle hyperplasia. Chronic obstructive pulmonary 
disease (COPD) is associated with a systemic inflammatory response, with elevated white 
blood cell (WBC) count and levels of c-reactive protein, fibrinogen, and cytokines, which 
have the potential to activate the vascular endothelium58;170. The prevalence of COPD 
50 
 
defined as FEV1/FVC<0.7 in our population was, however, too low to explain the findings, 
and the results persisted after elimination of all participants who reported any complaints of 
breathlessness. Thus this explanation is likely only if a systemic inflammatory response is 
initiated from a minor airway obstruction not recognized by the individual suffering from it 
and not included in the definition of COPD (FEV1/FVC<0.7).  
Interestingly, there seemed to be a sex difference in the association between FEV1 and early 
and late follow-up strokes, but the FEV1*sex interaction term failed to reach statistical 
significance. Such a difference, if real, might reflect a survivor effect and could 
hypothetically explain the increased overall stroke rate in females compared to males. A 
stronger association between FEV1 and stroke in females may be partly explained by sex 
differences in lung growth, and structure, and hormonal determinants of airway behavior17. 
For example, women are more susceptible to the effects of smoking than men28.  
The apparent lung-stroke association may be due to an unrecognized common offending 
factor which influences both stroke risk and lung function. In that case adjustments for 
longitudinal changes in lung function would minimize the stroke hazard associated with the 
baseline lung function. In the subgroup analysis performed in the male survivors in average 
23 years after baseline, the risk of fatal stroke was associated both with changes in lung 
function over time and with the baseline level. The adjusted effect estimate (HR) of 1.95 (p 
<0.05) associated with one liter reduction in FEV1 across baseline data, indicated a possible 
strong and independent association between baseline FEV1 and the risk of fatal stroke 
(though not formally statistically significant, probably due to lack of power).  
The association between baseline lung function and fatal stroke persisted after adjustments 
for decline in lung function during adult life, which suggests that the lung-stroke association 
could not be solely explained by confounding mechanisms acting during adulthood.  
To our knowledge this is the first study that reports on the association between lung function 
measurements and the risk of fatal stroke with a follow-up period longer than 20 years and it 
is the only study with adjustments for individual FEV1-changes over time. The cohort was 
randomly selected from a general population of both sexes with an extraordinarily high 
participation rate (84%). The clinical characteristics of the study population generally 
resemble those found in the county services in the 1970’s. 22 The study recorded an 
extensive number of clinical variables for each of the participants that were used to adjust 
for potential confounding factors. Our results support those from other recently published 
population-based studies including both sexes 83;194, but in contrast to these we have used 
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the unadjusted FEV1 measure. Traditionally FEV1 is adjusted for age and body height to 
express FEV1 as a percentage of a predicted value. This adjustment hides the independent 
association between these three variables and stroke and therefore we examined the FEV1 
stroke association with progressive adjustments for age, height and other variables. 40   
Despite the very high attendance rate at the initial survey in 1965-71 (84%), all the 
participants had to be capable of attending the clinic in person, so frail and ill members of 
the target population are potentially underrepresented. This selection is, however, more 
likely to deflate than to exaggerate the association between level of lung function and excess 
risk of fatal stroke.  
Information on previous strokes or transient ischemic attacks was not available from the 
data records. The generated variable “atherosclerosis” was therefore a surrogate variable 
based on ischemic symptoms from the heart and legs only.  
There might be some residual confounding due to imprecise measurements of lifetime 
exposure to tobacco, but our analyses support the view that the association between lung 
function and stroke is independent of smoking. 83;194 Air pollution might represent further 
confounding 185, but the degree of atmospheric pollution in Bergen at this time was very 
low. 121 Occupational exposure to gas and dust was not measured, but socioeconomic status 
(which is related to occupational exposure) did not influence the association. Residual 
confounding from undiagnosed diabetes at baseline may be possible, but it seems less 
probable as the effect estimate (HR) of the lung-stroke association was the same in strata of 
diabetic and non-diabetic participants respectively. Obstructive sleep apnoea is increasingly 
described as an independent risk factor for stroke and might also confound the association. 
42 75% of the participants who smoked 10+ cigarettes per day were men and 77% were in 
the lower two tertiles of age at baseline (<56 years). The change in the association between 
smoking and fatal stroke from the univariate analyses to the multiple regression model is 
due to the fact that those smoking 10+ cigarettes per day died from other causes and at 
younger ages than those who died from stroke (competing risks). As an example the HR of 
death from ischemic heart disease (Eurocode 34) among the smokers of 10+ cig/day 
schemic heart disease was 1.39 [1.16-1.68], unadjusted compared to never smokers. It is 
conceivable that FEV1 reductions may be due to childhood bronchiolitis, broncho-
pulmonary dysplasia (although uncommon) or lung growth problems related to intra-uterine 
insults including maternal smoking. Information on these variables were not available from 
the baseline of our population study. 
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Finally, our outcome measure is based on fatal stroke diagnoses from the death certificates 
and not on measures of total-strokes. Previous studies have compared risk factors for stroke 
incidence and stroke mortality. 71;73 These have concluded that studies with information on 
stroke mortality are likely to give results applicable to stroke incidence. 
We conclude that lung function is consistently, independently, and persistently associated 
with the risk of fatal stroke for both men and women. The mechanism of the association is 
still unknown, it might be neither causal nor reversible, but the findings indicate that the 
association is apparent also prior to changes in FEV1 during adult life. FEV1 as a percentage 
of a predicted value might therefore be useful in identifying individuals at particular risk of 
future fatal strokes. 
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7 Conclusion 
1. We have shown substantial validity of fatal cerebral strokes and coronary deaths in 
Norwegian mortality statistics compared with autopsy data.  
2.   Our study confirms that a BMI below 22 kg/m2 is an independent predictive factor of 
long-term mortality in elderly persons. Clinical and nutritional management should 
be applied to elderly persons in this BMI-range in a more careful manner. A BMI up 
to 28 kg/m2 may not be associated with an increased risk of death in this age group, 
and elderly in this weight range should probably not be advised to reduce. The cut-
off limits for BMI given by the WHO of 18.5 kg/m2 and 25.0 kg/m2 for normal 
weight and overweight, respectively, seem to have limited clinical applicability at 
least in geriatric medical practice in Norway. 
3. Mortality attributable to inactivity is substantial in all age ranges. Motivating elderly 
people and supporting them in the pursuit of physical activity should be given as 
much attention as the traditional risk intervention measures. 
4. Lung function is consistently, independently, and persistently associated with the 
risk of fatal stroke for both men and women. The mechanism of the association is 
still unknown, it might be neither causal nor reversible, but the findings indicate that 
the association is apparent also prior to changes in FEV1 during adult life. FEV1 as a 
percentage of a predicted value might therefore be useful in identifying individuals 
at particular risk of future fatal strokes.  
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8 Suggestions for further research 
1. Later follow-up of the cohort to increase the power of our study regarding cause-
specific mortality. 
2. Study the risks of cerebral hemorrhage versus infarction by using autopsy findings. 
3. Study of a dose-respond relationship between PA and mortality has not yet been 
established in the older age-ranges.  
4. Studies of the association between other cause-specific mortalities (ischemic heart 
disease, lung cancer and chronic respiratory diseases) and lung function, BMI and 
physical activity. 
5. Studies of how systemic inflammation markers in the elderly affect cause specific 
mortality. 
6. Studies on early life event (in utero or childhood) and associations with cause 
specific deaths in the elderly 
7. Studies on the efficiency of educational interventions on healthy life-style including 
physical activity, optimal body-weight and lung function achievement. 
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Abstract Mortality statistics represent important end-
points in epidemiological studies. The diagnostic validity
of cerebral stroke and ischemic heart disease recorded as
the underlying cause of death in Norwegian mortality
statistics was assessed by using mortality data of partici-
pants in the Bergen Clinical Blood Pressure Study in
Norway and autopsy records from the Gade Institute in
Bergen. In the 41 years of the study (1965–2005) 4,387
subjects had died and 1,140 (26%) had undergone a post
mortem examination; 548 (12%) died from cerebral stroke
and 1,120 (24%) from ischemic heart disease according to
the mortality statistics, compared to 113 (10%) strokes
and 323 (28%) coronary events registered in the autopsy
records. The sensitivity and positive predictive value of
fatal cerebral strokes in the mortality statistics were 0.75,
95% conﬁdence interval (CI) [0.66, 0.83] and 0.86 [0.77,
0.92], respectively, whereas those of coronary deaths were
0.87 [0.84, 0.91] and 0.85 [0.81, 0.89] respectively.
Cohen’s Kappa coefﬁcients were 0.78 [0.72, 0.84] for
stroke and 0.80 [0.76, 0.84] for coronary deaths. In
addition to female gender and increasing age at death,
cerebral stroke was a negative predictor of an autopsy
being carried out (odds ratio (OR) 0.69, 95% CI [0.54,
0.87]), whereas death from coronary heart disease was not
(OR 1.14, 95% CI [0.97, 1,33]), both adjusted for gender
and age at death. There was substantial agreement
between mortality statistics and autopsy ﬁndings for both
fatal strokes and coronary deaths. Selection for post
mortem examinations was associated with age, gender and
cause of death.
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Introduction
The speciﬁc cause of death reported in mortality statistics
is a common endpoint in epidemiological studies and it is
generally used as a surrogate marker of morbidity. Ische-
mic heart disease and cerebral stroke are the two leading
causes of death in the industrialized parts of world
according to mortality statistics [1 265/id]. Both the dis-
ability and mortality attributable to vascular disease in
ageing populations highlight the need to identify factors
related to aetiology and prevention.
Despite the decreasing autopsy rates, post mortem
examination is still regarded as the most accurate means of
determining the cause of death [2 299/id, 3 285/id].
Previous studies on the validity of cerebrovascular
mortality rates against autopsy ﬁndings have concluded,
contradictorily, both that the numbers are unacceptable
[4 288/id] and that the overall numbers are largely reliable
[5 239/id]. During the last two decades, as diagnostic
technology and procedures have continued to improve, only
a limited number of studies have been published validating
mortality statistics on stroke or ischemic heart disease
against autopsy ﬁndings [6 304/id, 7 276/id, 8 282/id].
These studies were based on cohorts selected for post-
mortem examinations, and thus not able to address external
validity. In Norway, the ofﬁcial department known as Sta-
tistics Norway compiles information on time and cause of
death for all deceased inhabitants. The mortality statistics
regarding stroke and ischemic heart disease in Norway have
not been validated against autopsy ﬁndings since 1977 [5
239/id].
The aims of this study were to compare the accuracy of
the diagnoses given in the mortality statistics between
stroke and ischemic heart disease against autopsy ﬁndings,
and to identify predictors of a general post mortem
examination being carried out.
Methods
Study population
A random, population-based sample of 6,811 subjects
aged 20–75 in 1964 was invited to the Bergen Clinical
Blood Pressure Survey (1965–1971). Information from
their medical history and from a standardized clinical
examination was recorded for each of the participants.
The study details have been extensively described else-
where [9 266/id, 10 154/id]. Registration of mortality
began on 1 January 1964 and ended on the date of death,
date of emigration or on 31 December 2005, whichever
occurred ﬁrst.
Mortality statistics
Since 1964 all residents of Norway have been assigned a
unique 11-digit identiﬁcation number which includes their
date of birth. Name, address and identiﬁcation number are
registered by the Central Population Register of Statistics
Norway, which by law must be kept up-to-date regarding
deaths and emigration. When a registered Norwegian dies
inside Norwegian borders, a death certiﬁcate is issued by a
physician, and sent to Statistics Norway. A death registered
on the basis of a medical death certiﬁcate is matched with
the corresponding identiﬁcation number in the Central
Population Register. The registered underlying cause of
death is the disease (or injury) that initiates the series of
events that eventually leads to death [11 305/id]. Notiﬁ-
cation of time, place and cause of death were obtained from
Statistics Norway and linked to our data ﬁle on the basis of
the identiﬁcation numbers, with permission granted by the
Data Inspectorate, the Norwegian Directorate of Health and
Social Services, and the Regional Committee for Ethics in
Medical Research. Statistics Norway used the 7th, 8th, 9th
and 10th revision of the International Classiﬁcation of
Diseases (ICD) during the study period from 1964 to 2005
(Table 1). The causes of death were grouped into the 65
causes in the ‘‘European shortlist’’ (Eurocodes) which are
used in the European ofﬁcial mortality statistics [12 307/
id]. The analyses were based on mortality from ischemic
heart disease (Eurocode 34, ICD10 I20–I25) and cerebro-
vascular disease (Eurocode 36, ICD10 I60–69), having
been given as the underlying cause of death.
Autopsy records
The autopsy assessments of the causes of death in this
cohort have previously been published [13 290/id].
Necropsy ﬁndings were recorded by means of SNOMED
codes. The Norwegian SNOMED has been prepared by the
Norwegian Pathology Association Code and Nomenclature
Committee in cooperation with the Competence Center for IT
in the health and social sector, and is based on the Systema-
tized Nomenclature ofMedicine [14 291/id]. The selection of
SNOMED codes which identiﬁes autopsy-veriﬁed fatal
Table 1 ICD codes (and corresponding ICD versions) used in Nor-
way during the study period covered by the variables fatal stroke and
coronary death [22 292/id]
Year of death ICD-version
in use
Fatal stroke
(Eurocode 36)
Coronary death
(Eurocode 34)
1964–1968 6/7 330–334 420, 422
1969–1985/
1986–1995
8/9 430–438 410–414
1996–2005 10 I60–I69 I20–I25
A. K. Gulsvik et al.
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strokes and coronary deaths is given in Table 5 in the
‘‘Appendix’’.
Statistical analyses
The causes of death recorded in the mortality statistics and
at autopsy from the Gade Institute Department of Pathology
were compared and tabulated according to the following
categories:
True positive: a correct match with the diagnosis from
the mortality statistics and at autopsy.
Over-diagnosed (false positive): case diagnosed in the
mortality statistics but not at autopsy. Over-diagnosed (%)
is the proportion of false positives divided by all the
positives according to the mortality statistics (test).
Under-diagnosed (false negative): case diagnosed at
autopsy but not in the mortality statistics. Under-diagnosed
(%) is the proportion of false negative cases divided by all
the positives according to the autopsy records (truth).
Sensitivity of the diagnosis in mortality statistics was
calculated as the proportion of true positives divided by all
the positives according to autopsy records.
Positive predictive value (PPV) was calculated as the
number of true positives divided by all the positives
according to the mortality statistics.
Overall agreement between the mortality statistics and
the autopsy results was assessed by Cohen’s kappa and its
95% conﬁdence interval [15 297/id]. Kappa can be inter-
preted as the proportion of agreement beyond chance, and
Cohen’s kappa is the most commonly used kappa-type
statistic in epidemiological studies [16 296/id]. We adopted
the Landis and Koch classiﬁcation [17 295/id], classifying
kappa between 0.00 and 0.20 as poor agreement; 0.21–0.40
fair agreement; 0.41–0.60 moderate agreement; 0.61–0.80
substantial agreement, and 0.81–1.00 almost perfect
agreement. Cox proportional hazard regression was used to
test the inﬂuence of hypertension upon stroke mortality or
death from ischemic heart disease deﬁned by mortality
statistics (Eurocode 36 or 34) and autopsy records,
respectively, in order to assess whether the results were
comparable. Binary logistic regression was used to explore
potential predictors of autopsy. Analyses were performed
using SPSS software, version 15.0.
Results
Study population
By the end of 41 years of the study, 4,387 persons (64% of
the cohort) had died and 1,140 of these (26%) were
examined by autopsy at the Gade Institute. The ratio of
autopsies to the number of deaths decreased from 40% in
the period 1964–1975 to 11% in the period 1995–2005.
The autopsy ratio for the upper quartile of age at death (i.e.
84–103 years) fell from 25 to 4%. In participants dying
from stroke (according to mortality statistics), the autopsy
ratio decreased from 41 to 4%, whereas in those dying from
coronary heart disease it decreased from 38 to 14%.
Of the 1,140 subjects examined by autopsy at the Gade
Institute in Bergen only 742 (65%) of the autopsy-reports
were forwarded and/or recorded in the mortality statistics
(Fig. 1).
Of the speciﬁc causes of death recorded in mortality
statistics, 3,389 (77%) were not based on autopsy ﬁndings.
The 256 cases of death recorded at Statistics Norway as
having been examined by autopsy, but with no autopsy
record at the Gade Institute, were evenly distributed over
the entire period of the study (‘‘Appendix’’ Fig. 2). Until
1996 Statistics Norway recorded that the registered cause
of death was based on an autopsy if the physician issuing
the Death Certiﬁcate had indicated that an autopsy had
been planned, but in many of these instances a post mortem
examination never took place. The 398 individuals with
autopsy records available at the Gade Institute, but with
cause of death ‘‘not based on autopsy’’ in the mortality
statistics died mainly in the period before 1987 when
physicians ordering the post mortem examination were still
responsible for forwarding the results of the autopsy to
Statistics Norway. From 1987 the pathology departments
were responsible for forwarding the autopsy reports and
from 1996 Statistics Norway implemented systematic
procedures to adjust the registered cause of death according
to the ﬁndings of the autopsy (‘‘Appendix’’ Fig. 3).
Validity of the diagnosis of fatal strokes in Norwegian
mortality statistics
The validity of the diagnosis of fatal stroke in the mortality
statistics was assessed by comparing the mortality statistics
for which diagnosis had been based on autopsy results with
those for which it had not (Table 2). The prevalence of
fatal strokes in the mortality statistics was the same in the
two groups (34/398 = 8.5 vs. 64/742 = 8.6%).
Ofthe28under-diagnosed(falsenegative)fatalstrokesinthe
mortalitystatistics,theregisteredcausesofdeathwerediseases
of thecirculatory system(Eurocode33) in12cases (including
ischemic heart disease (Eurocode 34) in 9 cases), pneumonia
(Eurocode39)in5cases,malignantneoplasm(Eurocode07)in4
casesandotherEurocodesin7cases.
Of the 13 over-diagnosed (false positive) fatal strokes
reported in the mortality statistics, the autopsy had identi-
ﬁed diseases of the circulatory system in 9 cases (including
ischemic heart disease in 5 cases), diseases of the lungs/
airways in 2 cases, malignant neoplasm in 1 case and 1
other case.
Validity of mortality statistics for fatal strokes and coronary deaths
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For fatal strokes the kappa coefﬁcient indicated ‘‘sub-
stantial’’ agreement irrespective of whether autopsy results
were available to inform the mortality statistics or not
(Table 2). The positive predictive value of fatal stroke in
mortality statistics was slightly improved when autopsy
results were available, but the change of sensitivity was
not statistically signiﬁcant (based on the overlapping of
conﬁdence intervals).
The kappa coefﬁcients calculated for the 4 different
quartiles of the follow-up period (before 1978, 1978–1986,
1987–1995, 1996–2005) were 0.83, 0.77, 0.70, and 0.85
respectively, showing no trend of increasing diagnostic
validity over time.
As hypertension is the most established risk factor for
cerebral stroke, we tested whether hypertension had pre-
dicted fatal stroke according to the mortality statistics
differently from fatal stroke according to the autopsy
records. We used Cox proportional hazard regression,
adjusted for age at the baseline examination (when the
blood pressure was measured) and for gender. With fatal
stroke from mortality statistics as the outcome the hazard
ratio was 1.71, 95% CI [1.4, 2.08] and as the outcome from
autopsy records the hazard ratio was 1.70, 95% CI [1.07,
2.68].
Validity of the diagnosis of coronary deaths
in Norwegian mortality statistics
As for stroke, the recorded coronary deaths in the mortality
statistics were divided into subgroups according to whether
the diagnoses were based on autopsy results or not, and the
validity of the mortality statistics was assessed (Table 3).
Study cohort at 
baseline (N 6811)
Dead by the end of 
follow -up (N 4387)
Cause of death recorded at Statistics Norway 
reported to be based on autopsy (N 998)
Autopsy reports available at 
the Gade Institute (N 1140) 
742
398
256
Fig. 1 Mortality and autopsy
data for the 6,811 survey
participants
Table 2 Validity of fatal strokes (Eurocode 36) recorded in Norwegian mortality statistics for 1,140 post mortem examinations, according to
whether the autopsy results were available or not
Eurocode 36 Sensitivity
[95% CI]
Positive predictive value
[95% CI]
Over-diagnosed
[95% CI]
Under-diagnosed
[95% CI]
Kappa
[95% CI]
Autopsy reported available 60/83 = 0.72 60/64 = 0.94 4/64 = 0.06 23/83 = 0.28 0.80
[0.63, 0.82] [0.88, 1.00] [0.003, 0.12] [0.18, 0.37] [0.72,0.87]
Autopsy reported unavailable 25/30 = 0.83 25/34 = 0.74 9/34 = 0.29 5/30 = 0.17 0.76
[0.70, 0.97] [0.59, 0.88] [0.12, 0.41] [0.03, 0.30] [0.64,0.88]
Total 85/113 = 0.75 85/98 = 0.87 13/98 = 0.14 28/113 = 0.25 0.79
[0.67, 0.83] [0.80, 0.93] [0.07, 0.20] [0.17, 0.33] [0.73,0.85]
CI conﬁdence interval
A. K. Gulsvik et al.
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The prevalence of coronary deaths in the mortality statis-
tics was 79/399 (20%) in the subgroup where autopsy
results had been reported as unavailable, whereas it was
253/742 (34%) in the subgroup where autopsy results had
been reported as available.
Of the 40 under-diagnosed (false negative) coronary
deaths in the mortality statistics, the registered causes of
death were diseases of the circulatory system (Eurocode
33) in 20 cases (of which stroke (Eurocode 36) in 5 cases),
respiratory diseases (Eurocode 37) in 7 cases, malignant
neoplasm (Eurocode 07) in 7 cases and others in 6 cases.
Of the 48 over-diagnosed (false positive) coronary death
reports in the mortality statistics, the autopsy reports con-
cluded on diseases of the circulatory system in 20 cases (of
which stroke in 9 cases), diseases of the lungs/airways in
11 cases and malignant neoplasm in 2 cases, and others in
15 cases.
For coronary deaths the kappa coefﬁcient increased
from ‘‘substantial’’ to ‘‘almost perfect’’ agreement when
the autopsy results were available to the mortality statistics.
The sensitivity of ischemic heart disease in the mortality
statistics was slightly improved when the autopsy results
were available, but for the positive predictive value the
difference was not statistically signiﬁcant (based on the
overlapping conﬁdence intervals).
In the 4 quartiles of the study period the combined
kappa coefﬁcients were 0.81, 0.79, 0.81, and 0.83,
respectively.
With coronary death (Eurocode 34) from the mortality
statistics as the outcome the Cox proportional hazard ratio
associated with hypertension was 1.58, 95% CI [1.38,
1.82]. With coronary death veriﬁed from the autopsy
record as the outcome the hazard ratio was 1.52 95% CI
[1.17, 1.99], both adjusted for age at baseline and gender.
Predictors of post mortem examination
and the association to fatal stroke
The selection of deaths for autopsy in a general population
is not random. We tested the following potential predictors
for effect upon the odds of undergoing post mortem
examination: age at death (quartiles), period of death
(before 1987 vs. 1987 or later), gender, and cause of death
(cerebral stroke or coronary disease). The independent
variables were explored in bivariate and multivariate
analyses. Bivariate logistic regression included only the
predictor of interest and the outcome (autopsy). Multivar-
iate logistic regression included gender, age at death and
period of death. Cause of death was compared to all other
deaths (Table 4).
As can be seen from Table 4, death from cerebral stroke
was a negative predictor of referral for autopsy, whereas
death from coronary heart disease was not, both adjusted
for gender, period of death and age at death. Female gender
was also a negative predictor of autopsy. There was no
statistically signiﬁcant interaction between the categorical
variables included in these analyses.
Discussion
Our study indicates that the validity of fatal cerebral stroke
as well as that of coronary death in the Norwegian mor-
tality statistics for the city of Bergen seems to be satis-
factory. The kappa coefﬁcients, sensitivity and positive
predictive values range between 0.71 and 0.92. Our ﬁnd-
ings are largely supported by the limited number of pre-
vious studies in this area [7 276/id, 3 285/id, 6 304/id].
Forty years ago a Norwegian study based on autopsy
records [5 239/id] also concluded that the over-all ﬁgures
for stroke deaths are generally reliable in the mortality
statistics.
The kappa coefﬁcient of both the diagnoses fatal stroke
and ischemic heart disease in the mortality statistics did not
change signiﬁcantly during the study period or across the
different ICD versions in use (results not shown). This is
somewhat surprising, as we have experienced an increased
access to more advanced diagnostic procedures over the
last decades, improving the accuracy of both diagnoses in
general. The fatal strokes may be clinically more obvious
Table 3 Validity of coronary deaths (Eurocode 34) recorded in Norwegian mortality statistics for 1,140 post mortem examinations, according to
whether the autopsy results were available or not
Eurocode 34 Sensitivity
[95% CI]
Positive predictive value
[95% CI]
Over-diagnosed
[95% CI]
Under-diagnosed
[95% CI]
Kappa
[95% CI]
Autopsy reported available 219/237 = 0.92 219/253 = 0.87 34/253 = 0.13 18/237 = 0.08 0.84
[0.89, 0.96] [0.82, 0.91] [0.09, 0.18] [0.04, 0.11] [0.79,0.88]
Autopsy reported unavailable 65/87 = 0.75 65/79 = 0.82 14/79 = 0.17 23/87 = 0.25 0.73
[0.66, 0.84] [0.74, 0.91] [0.09, 0.26] [0.17, 0.36] [0.64,0.81]
Total 284/324 = 0.88 284/332 = 0.86 48/332 = 0.15 40/324 = 0.12 0.80
[0.84, 0.91] [0.82, 0.89] [0.11, 0.18] [0.09, 0.16] [0.76, 0.84]
CI conﬁdence interval
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than the non-fatal strokes and the diagnostic accuracy of
these cases may thereby be less inﬂuenced by the
increasing access to advanced technology. While the dis-
agreement between autopsy results and clinical diagnoses
remains fairly stable [18 303/id], the number of post
mortem examinations decreases. This may well result in an
increase in diagnostic errors in the future.
We found limited differences in the accuracy of the
mortality statistics according to whether the diagnoses
were autopsy-based or not. The value of an autopsy is only
adequately exploited if the results are correctly incorpo-
rated into mortality statistics. In previous studies up to 40%
of autopsied cases were not properly reported in mortality
statistics [19 300/id, 20 301/id]. The results from 421
(36%) autopsies conducted at the Gade Institute were not
taken into account by Statistics Norway (Fig. 1). These
autopsy results, which were mostly from the period before
1987, may not have been forwarded by the physician
ordering the post mortem examination. Some of the 256
cases without autopsy records at the Gade Institute, but
which had been reported as having autopsy results in the
mortality statistics, may have died and undergone autopsy
outside the city of Bergen. The routines regarding reception
and implementation of these data at Statistics Norway may
thus be in need of improvement. The proportion of non-
recorded autopsy results has decreased during the study
period but there might still be a potential for improvement.
Finally, we found that fatal stroke, increasing age and
female gender are negative predictors of post mortem
examination, whereas coronary deaths are not, which
agrees with the ﬁndings of a Finnish study [8 282/id]. It has
previously been shown that the location where death takes
place also contributes to the demand for autopsy (hospital
deaths are examined much more often than nursing home
deaths and death in surgical wards more often than deaths
in medical wards). Furthermore, more uncertain clinical
diagnoses tend to be selected for autopsy and the pathol-
ogists tend to favor the more unusual diagnostic groups [13
290/id, 21 302/id]. Lack of interest in autopsy may also
reﬂect lack of clinical involvement or therapeutic frustra-
tion. Thus the selection for post mortem examination is not
random.
Limitations to this study are the limited sample size and
that the necropsy ﬁndings are collected from a closed
cohort, whereas the ofﬁcial mortality statistics record
information on deaths in the entire (open) population. Thus
incidence rates may not be comparable across the autopsy
group and mortality statistics in general. Participation in
the Bergen Clinical Blood Pressure Survey was not a
predictor of selection towards autopsy (results not shown),
so our ﬁndings are roughly applicable to an age-matched
selection of subjects recorded in mortality statistics
between 1965–2005. We found under-representation of the
elderly, of females and of fatal strokes among the autopsy-
investigated deaths. This means that younger males, who
were not assumed to be dead from stroke (atypical
strokes?) tended to be examined post mortem. This skew-
ness would rather deﬂate than exaggerate the correlation
between mortality statistics and autopsy ﬁndings. The false
positive and false negative rates in this cohort ranged from
5 to 29%. Approximately half of the mismatches remained
inside the circulatory system, whereas the others were more
or less randomly distributed over the entire spectrum of
diseases, which reduces the risk of systematic errors.
Table 4 Predictors of autopsy for 4,387 subjects who died during follow-up
Autopsy OR bivariate (95% CI) OR multivariate (95% CI)
Yes (n = 1,140) No (n = 3,247)
Gender
Male 688 (59) 1,416 (45) 1 1
Female 475 (41) 1,763 (55) 0.57 (0.50, 0.66) 0.73 (0.63, 0.84)
Age at death
\68 410 (35) 651 (20) 1 1
68–75 366 (32) 690 (21) 0.84 (0.71, 1.01) 0.91 (0.76, 1.09)
76–83 258 (22) 900 (28) 0.46 (0.38, 0.55) 0.56 (0.46, 0.68)
84? 129 (11) 983 (31) 0.21 (0.17, 0.26) 0.32 (0.25, 0.41)
Year of death
1964–1986 747 (64) 1,316 (41) 1 1
1987–2005 416 (36) 1,908 (59) 0.38 (0.33, 0.44) 0.55 (0.47, 0.63)
Fatal stroke 100 (9) 448 (14) 0.58 (0.46, 0.72) 0.66 (0.52, 0.84)
Coronary death 336 (29) 785 (24) 1.25 (1.07, 1.45) 1.09 (0.93, 1.27)
OR Odds ratio, CI conﬁdence interval, n number of cases
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Epidemiological research using endpoints deﬁned as
fatal stroke or ischemic heart disease from mortality sta-
tistics is unlikely to be markedly biased and that the validity
regarding the fatal strokes is acceptable for this age-range.
Our ﬁndings may also be applicable to international
mortality statistics based on similar sources of data.
Conclusion
We have shown substantial validity of fatal cerebral strokes
and coronary deaths in Norwegian mortality statistics,
though there is still some potential for improvement.
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Appendix
See Table 5; Figs. 2, 3.
Table 5 Topographical and morphological SNOMED codes repre-
senting the underlying (alternatively immediate) cause of death from
autopsy records regarding fatal strokes and coronary deaths
Localisation T-code
Heart including
pericardium
31000, 32000, 32600, 32910, 33010, 33030,
35000, 38000, 39000, 39900, 43000, 43100
Brain 45510, X1110, X1120, X2000, X2070, X7000
Morphological ﬁnding M-code
Infarct 54700, 54705, 54720, 54750, 54790, 52000,
52110, 52200, 35100, 35101, 35190,
35300, 36050
Haemorrhage 37000, 37001, 37003, 37004, 38000
(also 58000, 32400, 324401, 32431,
32470, 32471 (if T-code represents brain))
32400, 324401, 32431, 32470, 32471
SNOMED Systematic Nomenclature of Medicine (pathology-coding
system), T-code topographical code, M-code, morphological code
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Fig. 2 Autopsy-based causes of death recorded in mortality statis-
tics and the respective availability of autopsy data at the Gade
Institute. [‘‘light grey’’ (N = 256 cases) denotes autopsies recorded
in the mortality statistics, though autopsy data were not registered at
Gade.]
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Fig. 3 Causes of death recorded without autopsy in mortality
statistics and the respective availability of autopsy data at the Gade
Institute. [‘‘dark grey’’ (N = 398 cases) denotes autopsies at the
Gade Institute, which were not registered in the mortality
statistics.]
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KEY MESSAGES 
 What is already known? 
An inverse association between lung function and the risk of fatal stroke has been 
suggested. 
 
What this study adds? 
The association cannot be explained by confounding from smoking, hypertension, 
diabetes, atherosclerosis, socioeconomic status, obstructive lung disease, physical 
inactivity, serum cholesterol, or body mass index. The association also persists in a 
subgroup of never-smokers, in a subgroup without respiratory symptoms and in survivors 
of the first 20 years of follow-up. 
 
The association between baseline lung function and fatal stroke persists after adjustments 
for the changes in lung function during 23 years of adult life, which suggests that the 
lung-stroke association may be due to a common offending factors acting during foetal or 
childhood life or a possible causal mechanism. 
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Abstract 
Background Previous studies, all of less than 20 years of follow-up, have suggested an 
association between lung function and the risk of fatal stroke. This study investigates the 
stability of this association in a cohort followed for four decades. 
Methods The Bergen Clinical Blood Pressure Survey was conducted in Norway in 1964-71.  
The risk of fatal stroke associated with forced expiratory volume after one second (FEV1) 
was calculated with Cox proportional hazards regression, making progressive adjustment for 
potential confounders. 
Results Of 5,617 (84%) participants with recorded baseline FEV1, 462 died from stroke 
over 152,786 subsequent person years of follow up according to mortality statistics of 2005; 
mean(SD) follow-up was 27(12) years. An association between baseline FEV1 (L) and fatal 
stroke was observed; HR 1.38 (95% confidence interval (CI):1.11, 1.71) and HR 1.62 (95% 
CI: 1.22, 2.15) for men and women, respectively (adjusted for age and height). The findings 
were not explained by smoking, hypertension, diabetes, atherosclerosis, socioeconomic 
status, obstructive lung disease, physical inactivity, cholesterol, or body mass index, and 
persisted in subgroups of never-smokers, subgroups without respiratory symptoms, and 
survivors of the first 20 years of follow-up. For male survivors with a valid FEV1 at follow-
up (1988-90) (n=953), baseline FEV1 (L) indicated a possible strong and independent 
association to the risk of fatal stroke after adjustments for individual changes in FEV1 
(mL/year) (HR 1.95 (95% CI: 0.98, 3.86)).  
Conclusion There is a consistent, independent, and long-lasting association between lung 
function and fatal stroke, probably irrespectively of changes during adult life.  
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Introduction 
Cerebral stroke is the second most frequent cause of death in the industrialized world, as it 
is in Norway, [1,2] and it is the leading cause of acquired and permanent disabilities. 
Adequate risk assessment for stroke and prophylactic interventions are essential to reduce 
the incidence and mortality of this devastating condition.  
The associations between lung function, respiratory symptoms, and stroke are still under 
discussion. [3,4] The relationship between lower lung function and risk of stroke has 
previously been reported for both stroke incidence and stroke mortality [5,6], and the 
association is independent of other risk factors including smoking. [7] Asthma has been 
related to stroke and macrovascular disease. [8,9] Some of the previous studies in this field 
were not population based and included men only. [5,10] The largest population based study 
reported a response rate of 73.6%. None of the studies published so far have been able to 
study the robustness of the association after more than 20 years of follow up, and all 
previous studies on this relationship are based on one baseline measure of lung function 
only. [11,12]  The robust relationship between lung function and vascular events may be 
due to a common, unrecognized, offending factor (foetal or lifetime exposure) that affects 
both FEV1 and the vascular system, or it may be due to a causally linked process. [11] If the 
risk of stroke were more strongly related to the rate of declining lung function than with the 
baseline lung function levels, this would suggest that the responsible mechanisms are 
mainly operating in adult life. [12]  
Thus, the aims of the present study are, in a general Norwegian population with both sexes 
represented, a long-term follow-up and a high response rate, to assess the independent 
association between baseline lung function as well as that of longitudinal changes in lung 
function and the risk of fatal stroke.  
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 Methods 
Study population  
The study cohort and methods have been extensively described elsewhere. [13,14] A 
random, population-based sample of 6,811 subjects aged 22-75 years was invited to the 
Bergen Clinical Blood Pressure Survey in 1965-71. Sixty-seven persons were excluded 
because they had died, and six were excluded because they had emigrated before the 
screening took place, leaving 6,738 eligible subjects. The study participants and non-
participants have been compared in a previous publication. [14] 3119 (85%) women and 
2534 (83%) men participated (p 0.04). The mean age was 47.0 and 47.5 years in the 
participants and nonparticipants respectively (p 0.26), but non-participants died at younger 
age for both genders. The mean number of years lost for non-participants compared to 
participants was 4.7 for men and 2.7 for women. (P<0.001, T-test, Fisher exact test).  In 
1988-90 the survivors of men initially aged 22-54 years and who still lived in Bergen 
(n=1154) were invited to participate in a follow-up survey. [15] The cohort is assumed to 
consist exclusively of Caucasians. The aim of the baseline survey was to examine the 
prevalence of smoking and cardiovascular risk factors in a general population and the long-
term effects from these. The study has been approved by the local committee of medical 
ethics and the institutional review board. 
Independent variables 
Lung function 
Details of the forced expiration manoeuvres have been described elsewhere. [15] Briefly, 
dry-wedge bellow spirometers (Vitalograph) were used both at baseline (P-model)[16] in 
1965-71 and at follow-up in 1988-90 (S-model). Trained technicians recorded the highest 
values of FEV1 and forced vital capacity (FVC) from at least two acceptable attempts. All 
values used in the analyses were corrected to body temperature and pressure saturated 
conditions (BTPS). [15] Baseline levels of FEV1 and FVC were expressed in litres (L) 
whereas the (longitudinal) changes in FEV1 and FVC between baseline and follow-up in 
1988-90 were expressed as millilitres per year (mL/year). The predicted values of FEV1 and 
FVC were calculated due to the prediction equations recently derived and published from 
the same geographic area. [17] As a supplement we performed standard adjustments for 
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FEV1 and FVC by expressing these variables as percentages of their respective predicted 
values (FEV1% and FVC% respectively) and dichotomized these into a lower and upper 
median. Information regarding bronchitis and asthma was obtained from self-reports. 
Chronic obstructive pulmonary disease (COPD) was defined from the spirometric 
measurements as FEV1/FVC<0.7%. 
Variables for adjustment
An extensive array of variables was recorded for each participant at baseline. We first tested 
the association between lung function and stroke for confounding from the following 
baseline variables: sex, age, body height, hypertension, diabetes, pre-existing 
atherosclerosis, self reported bronchitis and/or asthma, self reported dyspnoea, smoking 
habits, socioeconomic status, physical inactivity, body mass index and cholesterol. 
Information on exposure to passive smoking in childhood or “in uterus” was not available.  
Blood pressure (BP) was measured using a Mercury Sphygmomanometer, model Mark3, 
designed by Rose, Holland and Crowley. [18] Hypertension was defined as a systolic blood 
pressure of 140 mmHg or more, or a diastolic blood pressure of 90 mmHg or more.  
The diagnosis of atherosclerosis was based on a combination of the interviewing medical 
officer’s conclusions (after interviewing the respondents regarding their medical history and 
symptoms of intermittent claudication, angina pectoris and myocardial infarction) and 
information from the questionnaires. Information on previous transient ischemic attacks was 
not available.  
Current smoking was defined as the consumption of at least one cigarette per day, 10 grams 
of pipe-tobacco per week or 1 cigar per week for at least one year. A smoker who had 
stopped smoking more than one month before the baseline examination was regarded as a 
former smoker. The smoking habits were divided into five groups: lifetime non-smokers, 
former smokers, current smokers of pipe/cigars, current smokers of 1-9 cigarettes per day, 
and current smokers of 10 or more cigarettes per day. [19] 
Socioeconomic status was categorized according to the British Registrar General’s 
classification of occupations [20] ; white collar 1 and 2 (upper), blue collar 1 and 2 (lower) 
and “others” (including students, housewives, retired etc). Physical activity was 
dichotomized into active or inactive in which inactivity was defined as physical activity less 
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than Sunday strolls or gardening. Bronchitis and/or asthma only present before 15 years of 
age was defined as childhood asthma/bronchitis (yes/no) and asthma and/or bronchitis 
present after 15 years of age was defined as adult asthma/bronchitis (yes/no). Dyspnoea was 
recorded on a scale from 0=no respiratory difficulties to 7= constant dyspnoea, based on self 
report and physician-interview-conclusion. We dichotomized the dyspnoea-information into 
no (0) and any kind of dyspnoea (1).  
Serum (s) glucose and cholesterol was measured according to the Lipid Research Clinics 
Program, using a colorimetric three-channel auto analyser (Technicon Auto Analyzer II). 
[21] Diabetes was defined as either being known from an individual’s medical history, or 
being indicated by an incidental blood glucose level above 11.0 mmol/l.  
Ascertainment of outcome 
The outcome of interest was fatal stroke reported as the underlying cause of death from the 
death certificates. When a registered Norwegian dies inside Norwegian borders, a death 
certificate is issued by a physician, and sent to Statistics Norway. The registered underlying 
cause of death is the disease (or injury) that initiates the series of events that eventually 
leads to death. [22] The physician issuing the death certificate uses available information 
from hospital records, clinical post mortem examination or other sources to complete the 
form. Statistics Norway (the country’s compiler and keeper of all national statistics) has 
linked information on emigration, time and the underlying cause of death from September 
1965 until December 2005 to the data-file using the National Identity Numbers for all the 
invited subjects. The causes of death were grouped into the 65 causes in the "European 
shortlist" (Eurocodes) which are used in the European official mortality statistics. [23] 
Eurocode 36 denotes fatal stroke and includes all stroke sub-types. The codes from 
International Classifications of Diseases (ICD-codes) used to identify fatal strokes are listed 
in Table 1.  
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Table 1. The ICD-codes Used to Identify Fatal Cerebral Stroke (Eurocode 36) in the Cause 
of Death Register in the Period 1965-2005. 
Year of death ICD-version  ICD-code 
1964-68 6/7 330-334 
1969-85 8 430-438 
1986-95 9 430-438 
1996-2005 10 I60-I69 
ABBREVIATIONS: ICD: International Classifications of Diseases 
The validity of fatal cerebral strokes reported as the underlying cause of death in mortality 
statistics for this cohort had a Cohen’s kappa coefficient of 0.79, sensitivity of 0.75, and a 
positive predictive value of 0.87 by comparison to autopsy findings. [24] Data on non-fatal 
strokes were not available. 
Statistical analyses  
The strength of the association between lung function and fatal cerebral stroke was assessed 
using Cox proportional hazards models. Firstly we used quartiles of baseline FEV1 and 
secondly we used quartiles of change in FEV1 (longitudinal) in univariate analyses. Both 
these analyses showed an approximately linear trend in the association between lung 
function measurement and fatal stoke, enabling us to investigate the FEV1-measures further 
on as continuous variables on an inverse scale (the hazard ratios calculated are per litre 
lower level in FEV1 for baseline data, and per ml/year decrease in FEV1 across longitudinal 
data).  
The Cox assumption of proportional hazards over time was assessed by plotting partial 
residuals from the Cox analysis of the FEV1-stroke association against time of follow-up. 
The association was also studied in the first and second halves of the follow-up time 
separately.  
Interactions between FEV1 and other explanatory variables were included one by one and 
excluded from the model if not statistically significant at the 5 % level.  
9 
 
We then performed univariate analyses of multiple variables potentially affecting the 
association between lung function and fatal stroke, and additionally univariate analyses of 
FEV1% (cut point of median), FVC% (cut point of median), and FEV1/FVC<0.70 (yes/no),
with chi-square tests and T-tests used when appropriate.  
Age, body height and sex are the variables included in the standard prediction models of 
both FEV1 and FVC. [17] These variables were therefore chosen to be included in the 
adjusted Cox proportional hazard model. The assessment of confounding beyond age, body 
height and sex was accomplished by comparing the effect estimate obtained from 
calculations including just FEV1, sex, age and height with the estimate obtained after the 
additional inclusion of each of the selected potential confounders. [25] Variables that were 
significant on a 5% level and that changed the estimate of the effect of FEV1 with more than 
10% were included in the model. 
Subgroup analyses were also performed in lifetime non-smokers (never/ever), in a subgroup 
of participants reporting no subjective dyspnoea (yes/no), and in a subgroup without 
diabetes, hypertension or history of atherosclerosis (neither/any), adjusting for sex, age, and 
body height only (the main model). 
 A multiple regression model was finally carried out to illustrate the effect of further 
adjustments, including FEV1, sex, age at baseline, body height, smoking habits (5 
categories), hypertension (yes/no), diabetes (yes/no), serum cholesterol (cut point of 
median), presence of atherosclerosis (yes/no), and physical inactivity (yes/no).  
Finally we studied the subgroup of participants with recorded measurements of FEV1 both at 
baseline and in 1988-90. This enabled us to compare the strength of the association for 
baseline data and for longitudinal data respectively, and the effect of corresponding 
adjustments. Score tests were used to assess model fit for baseline data compared to change 
over time. Analyses were computed with SPSS (version 15.0) software. 
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Results 
Of the 6,738 eligible subjects, 2,534 (83%) men and 3,119 (84%) women participated in the 
study. The proportion of fatal stroke was (467/3597) 13.0% among the study participants 
and (81/790) 10.3% in the non-participants who had died during follow-up. The odds of 
death from fatal stroke was 1.31 95%CI [1.02-1.69], p 0.03, in the participants compared to 
non-participants (logistic regression, adjusted for age at baseline and sex), but the OR was 
1.14 and non-significant when adjusted for age at death instead of age at baseline. The 
participants reached a higher age at death causing the prevalence of fatal stroke to be higher 
(competing risks).  
Among the participants, the percentage of cases with recorded data on FEV1, FVC, sex, age, 
body height, blood pressure, s-cholesterol, smoking habits, self-reported breathlessness, 
atherosclerosis, socioeconomic status, history of bronchitis and asthma, diabetes, and 
physical inactivity varied between 96 and 100 %. Blood glucose measurements were done 
for 3,509 participants (62%). Of the male survivors initially aged 22-54 years (n=1316), 
altogether 162 men had moved out of the study area by follow-up in 1988-90. Therefore, 
1154 men were invited at follow-up and 1032 (89%) participated and 953 (83%) obtained 
valid spirometric measurements at both baseline and follow-up.  
The total follow-up time for the cohort with recorded data on FEV1 was 152,786 person 
years and the mean±SD follow-up time was 25±12 and 29±11 years for men and women, 
respectively. By the end of 2005, 1714 (68%) men and 1850 (60%) women had died. From 
these, 186 (10.9%) men and 276 (14.9%) women had died from a stroke (Eurocode 36). [23] 
The characteristics of the study cohort are presented in Table 2. 
 
 Table 2. Characteristics of 5617 Participants with Valid Lung Function 
Measurements at Baseline in 1965-71. 
Baseline examination 1965-71: 
Men 
n=2525 
Women 
n=3092 
p
FEV1(L), mean(SD) 3.9(1.0) 2.8(0.7) <0.05 
FEV1 % (lower median), n(%) 1171(46) 1637(53) <0.05 
FVC (L), mean(SD)  4.9(1.1) 3.4(0.8) <0.05 
FVC% (lower median), n(%) 1131(45) 1671(54) <0.05 
Self reported childhood bronchitis or asthma, n(%) 208(8.3) 273(8.8) 0.33 
Self reported adult bronchitis or asthma, n(%) 244(9.7) 311(10.1) 0.33 
COPD, FEV1/FVC<0.70, n(%) 318(13) 134(4.3) <0.05 
Dyspnoea (scale 1-7), n(%) 344(14) 758(25) <0.05 
Age (yrs), mean(SD) 47(14) 48(14) <0.05 
Body height (m), mean(SD) 1.75(7) 1.61(6) <0.05 
BMI (kg/m2), mean(SD) 24.1(3.0) 24.2(4.4) <0.05 
Smoking habits    
Lifetime non-smoker, n(%) 392(16) 1925(63) 
Former smoker, n(%) 461(18) 144(5) 
Smoking of pipe or cigars, n(%) 240 (10) 2(0) 
Smoking 1-9 cig/day, n(%) 741(29) 783(25) 
Smoking 10+ cig/day, n(%) 688(27) 236(8) 
<0.05 
Systolic blood pressure (mmHg), mean(SD) 132(22) 135(28) <0.05 
Diastolic blood pressure (mmHg), mean(SD) 74(13) 74(13) 0.453 
Hypertension, n(%) 780(31) 1157(37) <0.05 
s-cholesterol (mmol/l), mean(SD) 6.6(1.4) 7.0(1.6) <0.05 
s-glucose (mmol/l), mean(SD) 5.6(1.6) 5.4(1.3) <0.05 
Diabetes, n(%) 64(2.5) 47(1.5) <0.05 
Atherosclerotic disease, n(%)   160(6.3) 137(4.4) <0.05 
Lowest category of socioeconomic status, n(%)   1450(57) 932(30) <0.05 
Physical inactivity, n(%) 417(17) 781(25) <0.05 
Follow-up until Dec 2005:     
Deaths, n(%) 1714(68) 1850(60) <0.05 
Fatal strokes, n(%) 186(10.9) 276(14.9) <0.05 
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ABBREVATIONS: SD: standard deviation; FEV1: Forced expiratory volume in one second; FEV1%: Forced expiratory volume in one 
second as percentage of the predicted value; FVC: Forced Vital Capacity, FVC%: Forced Vital Capacity as percentage of the predicted 
value; mmHg: millimetres of mercury; cig/day: number of cigarettes consumed per day. COPD: Chronic Obstructive Pulmonary Disease. 
 
Since FEV1 showed a closer association with fatal stroke than FVC in the preliminary 
univariate analyses, we chose to continue the calculations with FEV1 only (Table 3). The 
association between stroke and level of FEV1 was initially calculated separately for men and 
women using Cox proportional hazard regression models with progressive adjustments for 
age, body height and different potential confounders. Age, body height and sex are the 
variables used in the prediction models for FEV1. [17] In the association between lung 
function and risk of fatal stroke the unadjusted HR[95%CI] was 2.6[2.3-2.9], the height-
adjusted HR[95%CI] was 3.3[2.9-3.8], the age-adjusted HR[95%CI] was 1.1[1.0-1.3], and 
the sex-adjusted HR[95%CI] was 3.5[3.1-3.9]. Since the age-adjustment resulted in a 
marked drop in the HR for FEV1, we also studied the lung-stroke association in different 
strata of age at baseline (tertiles). The overlapping 95% confidence intervals of these 
analyses indicated non-significant differences in the association between FEV1 and the risk 
of stroke with increasing age (HR of fatal stroke associated with FEV1 was 2.41, 95% CI 
[1.18-4.91] in age-range <40 years, and 1.41 [1.14-1.77] in age-range 56+ years at baseline, 
adjusted for sex, age and height). The hazard ratios of the FEV1*age and FEV1*sex 
interaction terms tested separately in the main model were 1.00 [0.99-1.01] and 1.02 [0.78-
1.33] respectively. We adjusted for sex instead of carrying out sex-stratified analyses in 
order to maintain power. After adjustments for sex, age and body height the other 
confounding variables changed the FEV1-related hazard ratio for a fatal stroke less than 10 
percent and thus were not included in the main model. 
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Table 3. The Association Between Lung Function and Fatal Cerebral Stroke Calculated 
With Different multiple regression models for adjustment in 2,525 Men and 3,092 Women 
Examined in 1965-71.  
 Hazard Ratio [95% CI] of Fatal Strokea 
 Univariate 
analyses 
 
Main model 
(Including baseline FEV1, sex, 
age, and body height) 
Multiple regression
 (Main model with further 
adjustments)b 
FEV1(L) 2.63 [2.34-2.95] 1.50 [1.27-1.78] 1.41 [1.19-1.69] 
FEV1% (lower median) 1.69 [1.41-2.03] - - 
FVC (L) 2.05 [1.86-2.26] - - 
FVC% (lower median) 1.34 [1.12-1.61] - - 
COPD (FEV1/FVC<70) 2.48 [1.82-3.38] - - 
Childhood bronchitis or 
asthma (yes/no) 
0.67 [0.47-0.97] - - 
Adult bronchitis or asthma 
(yes/no) 
1.41 [1.06-1.87] - - 
Dyspnoea (yes/no) 2.69 [2.19-3.31] - - 
Sex (Female) 1.10 [0.92-1.30] 0.51 [0.38-0.69] 0.61 [0.44-0.85] 
Age (yrs) 1.14 [1.13-1.15] 1.13[1.11-1.14] 1.12 [1.10-1.13] 
Body height (m) 0.96 [0.95-0.97] 1.00 [0.99-1.02] 1.00 [0.98-1.02] 
Smoking 10+cig/d 0.68 [0.51-0.92] - 1.45 [1.03-2.04] 
Hypertension (yes/no) 5.04 [4.18-6.08] - 1.81 [1.47-2.23] 
Diabetes (yes/no) 4.31 [2.78-6.69] - 2.53 [1.62-3.95] 
s-cholesterol 6.69 
mmol/l 
2.16 [1.79-2.61] - 0.99[0.81-1.20] 
Atherosclerosis (yes/no) 5.47 [3.94-7.59] - 1.69 [1.20-2.38] 
Physical activity 
(inactivity/activity) 
1.64 [1.33-2.01] - 1.16 [0.93-1.44] 
BMI (kg/m2) 1.10 [1.08-1.13] - - 
Socioeconomic status 
(low/high) 
1.17 [0.94-1.47] - - 
ABBREVIATIONS: FEV1: Forced expiratory volume in one second; FEV1%: Forced expiratory volume in one second as percentage of 
the predicted value; FVC: Forced Vital Capacity, FVC%: Forced Vital Capacity as percentage of the predicted value; mmHg: millimetres 
of mercury; cig/day: number of cigarettes consumed per day. COPD: Chronic Obstructive Pulmonary Disease; BMI: body mass index; 
HR: Cox proportional hazard ratio; CI: confidence interval;  
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a The hazard ratios express the risk associated with one litre lower level in FEV1 across baseline data. 
b including FEV1, sex, age, body height (Main model) and additionally including smoking habits, hypertension, diabetes, cholesterol 
(median), symptoms of atherosclerosis, and physical inactivity. 
 
The calculations of the main model were also carried out in a subgroup of lifetime non-
smokers (n=2317), in order to eliminate potentially unrecognized residual confounding from 
smoking, resulting in a HR of 1.88, 95%CI [1.39, 2.55] per litre lower level in FEV1. When 
we did subgroup analyses of the main model in participants without dyspnoea (n=4366) the 
HR was 1.47, 95% CI [1.16, 1.86] per litre lower level in FEV1. This was done in order to 
investigate whether the lung-function measurement would add information to stroke risk 
assessment in subjects free from respiratory symptoms. Finally we did subgroup analyses of 
the main model in participants without diabetes, hypertension and a medical history 
suggesting atherosclerotic symptoms (angina pectoris, intermittent claudication or 
myocardial infarction) at baseline (n=3507), HR 1.43, 95% CI [1.07, 1.90]. This was done 
in order to assess whether the relationship between poor lung function and the risk of stroke 
precedes the presence of atherosclerosis. The hazard ratios associated with FEV1 remained 
remarkably stable irrespective of the subgroups studied. 
A multiple regression analysis was finally carried out to illustrate that none of the 
confounding factors reported in other research could explain the association of interest.  
To minimize any bias from pre-clinical disease prior to baseline that could possibly lead to 
both reduced lung function and increased mortality from stroke, we performed a sensitivity 
(robustness) analysis where events from the first 5 years of the follow-up period were 
excluded. This changed the hazard ratio, associated with one litre lower level in FEV1 
across baseline data, from 1.38 95% CI [1.11-1.71] to 1.30 [1.02-1.66] and from 1.62 [1.22-
2.15] to 1.61 [1.20-2.15] for men and women respectively, indicating that this type of bias 
has not affected the results.  
Previous studies have shown that the impact of risk factors may differ between successive 
time periods. [26] We calculated the hazard related to the early (0-19 years) and the late (20-
40 years) of the follow-up period and found that these were comparable (Table 4). (The 
corresponding results for the entire follow-up period are given in Table 3, Main model) 
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Table 4. The Association Between Baseline Level of FEV1 and Fatal Cerebral Stroke 
During Early and Late Follow-up for 2,525 Men and 3,092 Women Examined in 1965-71, 
Adjusted for Age and Body-Heighta 
 
Early follow-up strokes 
0-19 years 
Late follow-up strokes 
20-40 years 
 N (strokes) HR 95 % CI N (strokes) HR 95 % CI 
Men 2,525 (102) 1.54* 1.18-2.10 1,666 (84) 1.13 0.78-1.64 
Women 3,080 (86) 1.60 0.98-2.60 2,363 (190) 1.62* 1.15-2.29 
Combined 
(adjusted for sex) 
5617 (188) 1.56* 1.23-1.97 4029 (274) 1.37* 1.07-1.76 
ABBREVIATIONS: CI: confidence interval; FEV1: Forced expiratory volume in one second; HR: Hazard ratio; N: number of fatal 
strokes.  P<0.05 
a The hazard ratios express the risk associated with one litre lower level in FEV1 across baseline data. 
 
Finally we explored the association between FEV1 and stroke-risk, after adjustments for 
changes in lung function during adult life. The final analyses were performed on a subgroup 
of 953 men who had recordings on FEV1 at both baseline and the follow-up examination in 
1988-90. The mean FEV1(SD) at baseline in this subgroup was 4.42 (0.83) litres. The mean 
decline in lung function per year between the baseline examination and the follow-up 
examination in 1988-90 was 53 (19) ml/year. Of the 953 men who had complete sets of data 
on FEV1 both at baseline and in 1988-90, 23 fatal strokes were recorded in the mortality 
statistics in the follow-up period running from the second FEV1 measurement (1988-90) 
until end of follow-up (2005). The association between the two different lung function 
measures and fatal stroke was explored using four different models. Model 1: unadjusted, 
Model 2: including only baseline FEV1, age, and body height, Model 3: including only 
change in FEV1 per year between baseline and the follow-up survey in 1988-90, age, and 
body height, and Model 4: including both baseline FEV1, change in FEV1 per year between 
baseline and the follow-up survey in 1988-90, age, and body height (Table 5). We found a 
better model fit with the baseline level of lung function than with the change in FEV1 (-2 log 
likelihood test).  
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Table 5. The Association Between Baseline FEV1, the Change in FEV1 During Adulthood 
(FEV1 change/year), and the Risk of Fatal Stroke (N=23) in 953 Men Examined both at 
Baseline (1965-71) and in 1988-90. 
Cox proportional hazard ratio of fatal stroke (HR)a 
[95% CI] 
 
Model 1 
(univariate analyses) 
Model 2 
(including only 
baseline FEV1, age, 
and body height) 
Model 3 
(including only FEV1 
change/year, age, and 
body height) 
Model 4 
(including both baseline 
FEV1, FEV1/year, age, 
and body height) 
Baseline FEV1 (L)  
2.36 
[1.45-3.84] 
1.48 
[0.79-2.77] 
- 
1.95 
[0.98-3.86] 
FEV1 
change/yearb 
(mL/year)  
1.02 
[1.00-1.04] 
- 
1.02 
[1.00-1.04] 
1.03 
[1.00-1.05] 
Agec (yrs) 
1.19 
[1.11-1.28] 
1.18 
[1.10-1.28] 
1.20  
[1.11-1.30] 
1.17 
[1.08-1.27] 
Body heightd (m) 
0.99 
[0.93-1.06] 
1.05 
[0.97-1.12] 
1.00 
[0.94-1.07] 
1.03 
[0.96-1.11] 
ABBREVIATIONS: FEV1 change/year: mean change in FEV1 per year between baseline and 1988-90, CI: confidence interval; FEV1: 
Forced expiratory volume in one second; HR: hazard ratio; N: number; ml/yr: millilitres per year; SD: standard deviation;  
a The hazard ratios express the risk associated with one litre lower level in FEV1 across baseline data or/and one ml/year decrease in FEV1 
across longitudinal data. 
b Calculated as the difference in FEV1 between baseline and at the follow-up survey in 1988-90, divided by the number of years between 
the two examinations. 
c age at baseline examination. 
d height at baseline
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Discussion 
We found a robust and long-lasting association between lung function and fatal stroke in 
both men and women. Our study adds further information on this issue because of the very 
long and complete follow-up period, high response rate, adjustments for a wide range of 
possible confounding factors, the minimization of bias from ill-health, and the subgroup 
analyses that show robust, persistent, associations in lifetime non-smokers, in participants 
reporting no respiratory difficulties and in those who had no signs of atherosclerosis at 
baseline.  
Our analyses shed light on some possible explanations for the association between lung 
function and the risk of vascular events. The results weigh against a hypothesis that reduced 
FEV1 may serve as an epiphenomenon for a common environmental offending factor that 
affects both the pulmonary and the vascular systems, as adjustments for the available, 
possible confounding factors and ill-health bias resulted only in minor changes on the risk 
estimates associated with FEV1.  
Another possible explanation for the association is that an inflammatory link exists between 
lung processes and cardiovascular disease. Inducing airway inflammation in rabbits can 
incite and propagate systemic inflammation, which in turn may contribute to the progression 
of atherosclerosis. [27] Low-grade systemic inflammation is a major risk factor for plaque 
genesis, progression and rupture. [28] FEV1 is known to be associated with carotid artery 
intimae-medial thickness [29] and is possibly a marker for smooth muscle hyperplasia. 
Chronic obstructive pulmonary disease (COPD) is associated with a systemic inflammatory 
response, with elevated white blood cell (WBC) count and levels of c-reactive protein, 
fibrinogen, and cytokines, which have the potential to activate the vascular endothelium. 
[11,30] The prevalence of COPD (FEV1/FVC<0.7) in our population was, however, too low 
to explain the findings, and the results were robust in a subgroup of participants who did not 
report any complaints of dyspnoe. Thus this explanation is likely only if a systemic 
inflammatory response is initiated from a minor airway obstruction not even recognized by 
the individual suffering from it.  
Interestingly, there seemed to be a  sex difference in the association between FEV1 and early 
and late follow-up strokes, but the FEV1*sex interaction term failed to reach statistical 
significance. Such a difference, if real, might reflect a survivor effect and could 
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hypothetically explain the increased overall stroke rate in females compared to males. A 
stronger association between FEV1 and stroke in females may be partly explained by sex 
differences in lung growth, and structure, and hormonal determinants of airway behaviour. 
[31] For example, women are more susceptible to the effects of smoking than men. [32]  
The apparent lung-stroke association may be due to an unrecognized common offending 
factor which influences both stroke risk and lung function. In that case adjustments for 
longitudinal changes in lung function would minimize the stroke hazard associated with the 
baseline lung function. In the subgroup analysis performed in the male survivors in average 
23 years after baseline, the risk of fatal stroke was associated both with changes in lung 
function over time and with the baseline level. The adjusted effect estimate (HR) of 1.95 (p 
0.05) associated with one litre reduction in FEV1 across baseline data, indicated a possible 
strong and independent association between baseline FEV1 and the risk of fatal stroke 
(though not formally statistically significant, probably due to lack of power).  
The association between baseline lung function and fatal stroke persisted after adjustments 
for decline in lung function during adult life, which suggests that the lung-stroke association 
could not be solely explained by confounding mechanisms acting during adulthood.  
Strengths and limitations 
A major strength of this study is the very long follow-up period and the access to 
longitudinal data on individual FEV1-changes over time. To our knowledge this is the first 
study that reports on the association between lung function measurements and the risk of 
fatal stroke with a follow-up period longer than 20 years and it is the only study with 
adjustments for individual FEV1-changes over time. The cohort was randomly selected from 
a general population of both sexes with an extraordinarily high participation rate (84%). The 
clinical characteristics of the study population generally resemble those found in the county 
services in the 1970’s. [33] The study recorded an extensive number of clinical variables for 
each of the participants that were used to adjust for potential confounding factors. Our 
results support those from other recently published population-based studies including both 
sexes [7,34], but in contrast to these we have used the unadjusted FEV1 measure. 
Traditionally FEV1 is adjusted for age and body height to express FEV1 as a percentage of a 
predicted value. This adjustment hides the independent association between these three 
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variables and stroke and therefore we examined the FEV1 stroke association with 
progressive adjustments for age, height and other variables. [12]   
Despite the very high attendance rate at the initial survey in 1965-71 (84%), all the 
participants had to be capable of attending the clinic in person, so frail and ill members of 
the target population are potentially underrepresented. This selection is, however, more 
likely to deflate than to exaggerate the association between level of lung function and excess 
risk of fatal stroke.  
Information on previous strokes or transient ischemic attacks was not available from the 
data records. The generated variable “atherosclerosis” was therefore a surrogate variable 
based on ischemic symptoms from the heart and legs only.  
There might be some residual confounding due to imprecise measurements of lifetime 
exposure to tobacco, but our analyses support the view that the association between lung 
function and stroke is independent of smoking. [7,34] Air pollution might represent further 
confounding [35], but the degree of atmospheric pollution in Bergen at this time was very 
low. [36] Occupational exposure to gas and dust was not measured, but socioeconomic 
status (which is related to occupational exposure) did not influence the association. Residual 
confounding from undiagnosed diabetes at baseline may be possible, but it seems less 
probable as the effect estimate (HR) of the lung-stroke association was the same in strata of 
diabetic and non-diabetic participants respectively (results not shown). Obstructive sleep 
apnoea is increasingly described as an independent risk factor for stroke and might also 
confound the association. [37] 75% of the participants who smoked 10+ cigarettes per day 
were men and 77% were in the lower two tertiles of age at baseline (<56 years). The change 
in the association between smoking and fatal stroke from the univariate analyses to the 
multiple regression model is due to the fact that those smoking 10+ cigarettes per day died 
from other causes and at younger ages than those who died from stroke (competing risks). 
As an example the HR of death from ischemic heart disease (Eurocode 34) among the 
smokers of 10+ cig/day schemic heart disease was 1.39 [1.16-1.68], unadjusted compared to 
never smokers. It is conceivable that FEV1 reductions may be due to childhood 
bronchiolitis, broncho-pulmonary dysplasia (although uncommon) or lung growth problems 
related to intra-uterine insults including maternal smoking. Unfortunately, information on 
these variables were not available. 
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Finally, our outcome measure is based on fatal stroke diagnoses from the death certificates 
and not on measures of total-strokes. Previous studies have compared risk factors for stroke 
incidence and stroke mortality. [6,38] These have concluded that studies with information 
on stroke mortality are likely to give results applicable to stroke incidence. 
We conclude that lung function is consistently, independently, and persistently associated 
with the risk of fatal stroke for both men and women. The mechanism of the association is 
still unknown, it might be neither causal nor reversible, but the findings indicate that the 
association is apparent also prior to changes in FEV1 during adult life. FEV1 as a percentage 
of a predicted value might therefore be useful in identifying individuals at particular risk of 
future fatal strokes.
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“Theory without fact is fantasy, but fact without theory is chaos.” 
C. W. Whitman, 1894 
 
 
 
 
“As persons, we are incomparable, unclassifiable, uncountable, and irreplaceable.” 
W. H. Auden, 1967 
 
 
 
 
 
 
 
 
